{"study_id": 70406, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of povidone-iodine (PI) in reducing bacterial contamination on the conjunctiva versus topical antibiotics (gatifloxacin and moxifloxacin).", "results_summary": "PI reduced bacterial growth by 28% and colony counts by 40%, showing statistically significant results. The study found no significant difference in effectiveness between PI and the antibiotics tested.", "population_specificity": "Fresh cadaver eyes (13 cadavers, both eyes).", "effective_dosage": "10% PI (soaked on eyes).", "study_duration": "Not specified (single intervention).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:13:54.543529+00:00"}
{"study_id": 70408, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the role of iodine contrast in CT imaging for detecting endoleaks post-EVAR and exploring alternative imaging methods to reduce iodine and radiation exposure.", "results_summary": "The study highlights that while CT with iodine contrast remains the gold standard for endoleak detection, it poses risks due to iodine exposure and radiation. Alternative methods like CEUS and MR imaging are proposed to mitigate these risks.", "population_specificity": "Patients who underwent endovascular aortic aneurysm repair (EVAR).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:13:56.390880+00:00"}
{"study_id": 70407, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate urinary and rectal toxicity profiles in patients undergoing permanent seed implantation (PI) and combination therapy with PI and external beam radiation therapy (EBRT).", "results_summary": "The study found higher acute urinary toxicity in the PI group compared to the EBRT group, while acute rectal toxicity was similar. Late rectal toxicities were significantly lower in the PI group compared to the EBRT group.", "population_specificity": "Patients enrolled in a nationwide multi-institutional cohort study (baseline data from 2339 subjects).", "effective_dosage": "Not mentioned", "study_duration": "Follow-up assessments were conducted up to 36 months after radiation therapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:13:57.095714+00:00"}
{"study_id": 70410, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize recent advances in PET and SPECT imaging for Alzheimer's disease pathophysiology, including the use of iodine-123 in SPECT.", "results_summary": "The abstract highlights the utility of PET and SPECT imaging, including iodine-123, for visualizing and quantifying tau aggregates and A\u03b2 plaques in Alzheimer's disease, but does not report specific results on iodine's effects.", "population_specificity": "Alzheimer's disease patients (implicitly, as the focus is on diagnostic imaging for AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:13:58.366399+00:00"}
{"study_id": 70409, "supplement_id": 1234, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the anti-infective profile, efficacy, and safety of povidone-iodine (PVP-I) in managing upper respiratory tract infections, oral mucositis, and dental conditions.", "results_summary": "PVP-I demonstrated broad-spectrum anti-infective activity with low resistance potential, offering benefits in infection control and prevention. However, there is discordance between evidence and clinical practice regarding its use in oropharyngeal infections compared to dermal applications.", "population_specificity": "Patients with upper respiratory tract infections, oral mucositis, periodontitis, and caries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:13:59.051300+00:00"}
{"study_id": 70411, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness, satisfaction level, and safety of rimabotulinumtoxinB with onabotulinumtoxinA at a conversion ratio of 1:30 for treating primary axillary hyperhidrosis (PAH).", "results_summary": "Both toxins showed comparable anhidrotic effects through 20 weeks, with no significant differences in onset or duration of action. Patient satisfaction was equally high in both groups.", "population_specificity": "Adults with primary axillary hyperhidrosis (PAH).", "effective_dosage": "1,500 U rimabotulinumtoxinB on one axilla and 50 U onabotulinumtoxinA contralaterally.", "study_duration": "Up to 20 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:13:59.221555+00:00"}
{"study_id": 70412, "supplement_id": 1234, "safety_score": "80", "efficacy_score": 75, "quality_score": 65, "study_goal": "To determine the patterns of dose rate reduction in single and multiple radioiodine (I-131) therapies in well-differentiated thyroid cancer patients.", "results_summary": "Rapid dose rate reduction was observed in patients receiving second or subsequent radioiodine therapy compared to first-time recipients. Most patients were discharged within 48 hours without major complications.", "population_specificity": "93 well-differentiated thyroid cancer patients (68 females, 25 males) aged 15-80 years.", "effective_dosage": "Single therapy doses ranged from 70 mCi (2590 MBq) to 150 mCi (5550 MBq); multiple therapy doses ranged from 80 mCi (2960 MBq) to 250 mCi (9250 MBq).", "study_duration": "Study conducted from December 2006 to December 2013.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:00.378833+00:00"}
{"study_id": 70413, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of cholestyramine as an additional treatment for refractory iodine-induced hyperthyroidism.", "results_summary": "Cholestyramine significantly reduced FT4 levels by 30% within 5 days and normalized them after 12 days in a patient with refractory hyperthyroidism, suggesting its efficacy as an adjunct therapy. The rapid response indicated it was unlikely due to natural remission.", "population_specificity": "A 52-year-old woman with refractory hyperthyroidism and obstructive goiter symptoms.", "effective_dosage": "Not specified (high-dose carbimazole, propranolol, and dexamethasone were used alongside cholestyramine).", "study_duration": "12 days (cholestyramine intervention).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:01.619475+00:00"}
{"study_id": 70414, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of radioactive iodine therapy in treating well-differentiated thyroid carcinoma, including its role in low-risk and high-risk tumors, and to assess new treatment options for iodine-resistant cases.", "results_summary": "Radioactive iodine therapy is highly effective for localized and metastatic well-differentiated thyroid carcinoma, with a 10-year survival rate of 90% when iodine uptake is good. For iodine-resistant cases, tyrosine kinase inhibitors can prolong progression-free survival but not overall survival.", "population_specificity": "Patients with well-differentiated thyroid carcinoma (primarily papillary), including those with localized tumors and distant metastases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:02.963280+00:00"}
{"study_id": 70415, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if iodine repletion decreases serum TSH and improves the lipid profile in iodine-deficient, overweight or obese women.", "results_summary": "Iodine supplementation significantly reduced TSH levels, improved thyroid hormone ratios, and decreased the prevalence of hypercholesterolemia, particularly in subjects with elevated baseline cholesterol.", "population_specificity": "Iodine-deficient, overweight or obese Moroccan women (n = 163).", "effective_dosage": "200 \u03bcg oral iodine daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:03.692863+00:00"}
{"study_id": 70416, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the image quality and diagnostic performance of late iodine enhancement (LIE) in dual-source computed tomography (DSCT) for detecting acute myocardial infarction (AMI) compared to late gadolinium enhancement (LGE) MRI.", "results_summary": "The study found that denoised 100-kVp images significantly improved contrast-to-noise ratio (CNR), diagnostic accuracy, and sensitivity for detecting AMI compared to other image types, with results correlating well with MRI findings.", "population_specificity": "19 patients who received percutaneous coronary intervention after AMI.", "effective_dosage": "Not specified (contrast medium administered at a slow injection rate).", "study_duration": "Not specified (scans performed before discharge).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:06.070544+00:00"}
{"study_id": 70417, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of iodine in Graves' disease treatment and the factors influencing relapse after antithyroid drug therapy.", "results_summary": "The study highlights that antithyroid drugs (ATDs) are first-line treatment in Europe but have high relapse rates, particularly in patients with large thyroid volume, smoking habits, persistent TRAb, or post-partum status. Definitive therapies like radioiodine or thyroidectomy are recommended for high-risk patients.", "population_specificity": "Patients with Graves' disease in iodine-replete areas.", "effective_dosage": "Not specified", "study_duration": "18-24 months (ATD treatment duration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:07.505896+00:00"}
{"study_id": 70418, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term effects of a patient decision aid (P-DA) on medical knowledge, decision satisfaction, and psychological outcomes in early-stage thyroid cancer patients considering radioactive iodine (RAI) treatment.", "results_summary": "The P-DA significantly improved patients' perceived knowledge about RAI treatment options, benefits, and risks, but did not affect decision satisfaction, regret, cancer-related worry, or physician trust. Qualitative analysis indicated increased patient confidence in decision-making.", "population_specificity": "Early-stage thyroid cancer patients at a Canadian tertiary/quaternary care center.", "effective_dosage": "Not specified", "study_duration": "Follow-up at 15 to 23 months after randomization/RAI decision-making.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:07.664864+00:00"}
{"study_id": 70419, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review recent clinical studies on how genetic variation in deiodinases (DIO1, DIO2, DIO3) influences health, including interactions with iodine and thyroid status.", "results_summary": "Common variation in DIO1 is associated with modest effects on thyroid hormone levels, while DIO2 variation (Thr92Ala) is linked to clinical endpoints like osteoarthritis and IQ, with mechanisms varying by tissue. Interaction with iodine and thyroid status is emerging but requires further study.", "population_specificity": "General population with genetic variations in deiodinases, potentially including those with iodine deficiency or thyroid disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interaction with iodine and thyroid status noted, but specifics not detailed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:08.226878+00:00"}
{"study_id": 70420, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the clinical association between hepatic uptake of radioactive iodine (I-131) on whole-body scans and the prognosis of differentiated thyroid cancer (DTC).", "results_summary": "The study found that hepatic uptake ratios (H/B) differed significantly among patient groups, with higher ratios associated with disease progression. A cutoff value of H/B \u22641.5 effectively distinguished patients who completed therapy from those requiring further treatment, demonstrating high diagnostic accuracy.", "population_specificity": "216 patients with differentiated thyroid cancer (DTC).", "effective_dosage": "Not specified (study analyzed postablative scans).", "study_duration": "Not specified (follow-up based on clinical outcomes).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:08.920685+00:00"}
{"study_id": 70421, "supplement_id": 1234, "safety_score": "60", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to review adverse drug reactions in breastfed infants, including those related to free iodine, opioids, and CNS drugs.", "results_summary": "The study found that serious acute adverse drug reactions from drugs in breastmilk, including free iodine, are uncommon, but infants under 2 months are most susceptible. Long-term effects of maternal drug therapy on breastfed infants were mostly reassuring.", "population_specificity": "Breastfed infants, particularly those under 2 months of age.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:09.037321+00:00"}
{"study_id": 70422, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term effects of a computerized patient decision aid (P-DA) on decision-making and outcomes related to adjuvant radioactive iodine (RAI) treatment in low-risk papillary thyroid cancer patients.", "results_summary": "The P-DA significantly improved patients' medical knowledge at the time of decision-making compared to usual care alone. The extended follow-up study will assess long-term outcomes such as decision satisfaction, regret, and cancer-related worry.", "population_specificity": "Patients with low-risk papillary thyroid cancer after total thyroidectomy.", "effective_dosage": "Not specified", "study_duration": "15 to 23 months post-randomization", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:11.934509+00:00"}
{"study_id": 70423, "supplement_id": 1234, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and therapeutic efficacy of percutaneous (125)iodine seeds implantation for treating portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients.", "results_summary": "(125)Iodine seeds were successfully implanted in all patients without serious complications, and the portal vein tumor thrombi significantly shrank during follow-up. The study concluded that the procedure is effective and safe for PVTT accompanying HCC.", "population_specificity": "Nineteen patients with hepatocellular carcinoma (HCC) accompanied by portal vein tumor thrombosis (PVTT).", "effective_dosage": "8-30 (125)iodine seeds implanted 8 mm apart within the portal vein tumor thrombi.", "study_duration": "Follow-up period ranged from 3 to 22 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:12.679169+00:00"}
{"study_id": 70424, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of the PI3K/Akt pathway in non-medullary thyroid carcinoma (TC) and explore its potential as a therapeutic target, particularly in cases resistant to radioactive iodine treatment.", "results_summary": "The abstract highlights the PI3K/Akt/mTOR pathway's significance in TC pathogenesis, especially in advanced or resistant cases, and discusses preclinical and clinical evidence supporting its targeting for systemic therapy. It suggests that orally available drugs targeting this pathway show promise for treating advanced TC.", "population_specificity": "Patients with advanced or radioactive iodine-resistant non-medullary thyroid carcinoma (follicular, anaplastic, or poorly differentiated TC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:15.012550+00:00"}
{"study_id": 70426, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to investigate thymus gland uptake of radioiodine as a potential cause of false-positive results in whole-body scintigraphy after ablation therapy for thyroid cancer.", "results_summary": "The study found that thymus gland uptake of radioiodine can occur in patients with papillary thyroid carcinoma after thyroidectomy and ablation therapy, leading to false-positive scintigraphy results. This highlights the need to consider thymus uptake as a diagnostic pitfall.", "population_specificity": "Two patients with papillary thyroid carcinoma, follicular variant, and cervical lymph node involvement.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:17.073603+00:00"}
{"study_id": 70425, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate hypothesized causes of the increased incidence of thyroid cancer, including iodine excess or insufficiency.", "results_summary": "The study found that the contribution of iodine excess or insufficiency to the increasing incidence of thyroid cancer is unclear, with no strong evidence supporting a direct link.", "population_specificity": "General population in the United States, focusing on thyroid cancer epidemiology.", "effective_dosage": "Not available", "study_duration": "Not applicable (epidemiological analysis)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:17.086167+00:00"}
{"study_id": 70429, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the justification for using radioactive iodine (RAI) ablation in low-risk differentiated thyroid carcinoma patients post-thyroidectomy.", "results_summary": "The study argues that RAI ablation effectively destroys post-surgical thyroid remnants, provides adjuvant therapy for residual/metastatic cancers, and enhances diagnostic accuracy, countering concerns about over-reliance on short-term studies and inflated side effects.", "population_specificity": "Patients with differentiated thyroid carcinoma, particularly those considered \"low-risk\" based on surgical findings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:18.356063+00:00"}
{"study_id": 70428, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers reviewed literature to evaluate the effectiveness of various treatments, including povidone iodine, for preventing and managing radiation-induced oral mucositis.", "results_summary": "The study found that topical povidone iodine, along with other agents, is useful for treating co-existing infections in radiation-induced oral mucositis, but its specific efficacy compared to other treatments was not detailed.", "population_specificity": "Patients undergoing radiotherapy for head and neck cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:18.878147+00:00"}
{"study_id": 70427, "supplement_id": 1234, "safety_score": "70", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of a low iodine diet (LID) in enhancing radioactive iodine (RAI) ablation efficacy for differentiated thyroid cancer (DTC) post-thyroidectomy.", "results_summary": "The study found that an LID (\u226450 mcg/day) for 1-2 weeks improves RAI uptake, with pre-ablation urinary iodine levels (<100 mcg/l) indicating adequate preparation. Hyponatraemia, though rare, was noted as a potential side effect, particularly in high-risk patients. The evidence on LID's impact remains inconsistent due to retrospective designs and lack of objective urinary iodine measurements.", "population_specificity": "Patients with differentiated thyroid cancer (DTC) post-thyroidectomy.", "effective_dosage": "\u226450 mcg/day of dietary iodine.", "study_duration": "1-2 weeks (or shortened to 1 week with structured education).", "interactions": "Thiazide diuretics may increase hyponatraemia risk during LID.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:19.195701+00:00"}
{"study_id": 70430, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of targeted therapies (sorafenib and lenvatinib) in treating advanced differentiated thyroid cancer refractory to radioactive iodine.", "results_summary": "The abstract highlights that sorafenib and lenvatinib represent major innovations for advanced thyroid cancer but acknowledges limitations, emphasizing the need for further research into personalized therapies.", "population_specificity": "Patients with progressive, symptomatic, radioactive iodine-refractory, advanced differentiated thyroid cancer.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:20.052895+00:00"}
{"study_id": 70431, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to assess the effects of prenatal home fortification with multiple micronutrient powders, including iodine, on maternal and newborn health compared to other supplementation methods.", "results_summary": "The study found no clear difference in maternal anemia at 37 weeks between micronutrient powders and multiple micronutrient supplements, with very low-quality evidence. Adherence to micronutrient powders was lower than to tablets.", "population_specificity": "Pregnant women of any gestational age and parity.", "effective_dosage": "Not specified for iodine alone; micronutrient powders contained iron, folic acid, vitamin C, zinc, iodine, vitamin E, and vitamin B12.", "study_duration": "From 14-22 weeks to 32 weeks' gestation in one trial; duration not specified for the other.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:21.525941+00:00"}
{"study_id": 70432, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine how patients' baseline information preference style influenced their acquisition of detailed information from a computerized decision aid (P-DA) and their medical knowledge regarding adjuvant radioactive iodine treatment for early-stage papillary thyroid cancer.", "results_summary": "High monitoring (information-seeking) preference moderately correlated with more detailed information acquisition from the P-DA and weakly correlated with increased medical knowledge overall, but no significant associations were found with blunting (information-avoidance) preferences.", "population_specificity": "Early-stage papillary thyroid cancer patients considering adjuvant radioactive iodine treatment.", "effective_dosage": "Not specified", "study_duration": "One-time viewing of the P-DA", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:22.932917+00:00"}
{"study_id": 70434, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to compare the effectiveness and safety of octenidine-based antiseptic versus povidone iodine (PVP-iodine) in split-thickness skin grafts for high-risk patients with impaired wound healing.", "results_summary": "The study found that PVP-iodine led to graft necrosis in one patient, while octenidine resulted in successful healing in both cases, suggesting better efficacy for high-risk patients.", "population_specificity": "High-risk patients (smokers with diabetes, one also on corticosteroids) requiring split-thickness skin grafts.", "effective_dosage": "Not specified", "study_duration": "5 days for the first patient (PVP-iodine); duration for octenidine not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:25.988702+00:00"}
{"study_id": 70433, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate current diagnostic and treatment modalities for Graves' disease in pediatric populations, focusing on the efficacy and controversy surrounding permanent therapy options like radioactive iodine ablation.", "results_summary": "The study found that Graves' disease in children is often diagnosed clinically, with improved confirmation via advanced thyroid-stimulating hormone receptor antibody assays. Despite low remission rates, radioactive iodine ablation is increasingly favored for permanent therapy when medical treatment fails.", "population_specificity": "Pediatric patients, particularly adolescents and prepubertal children with Graves' disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:26.038599+00:00"}
{"study_id": 70438, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the quality of evidence for povidone iodine as a preventive measure for early childhood caries (ECC).", "results_summary": "The study found insufficient quality of evidence to support the use of povidone iodine for preventing or managing ECC. No significant benefits were demonstrated.", "population_specificity": "Children with or at risk of early childhood caries (ECC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:27.139082+00:00"}
{"study_id": 70436, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 30, "study_goal": "To describe a degenerative vascular change in a treated choroidal melanoma that clinically simulated late treatment failure.", "results_summary": "The study found that late degenerative changes in the vasculature of a treated uveal melanoma resulted in tumor enlargement, mimicking treatment failure, though histologically the tumor showed no mitotic activity or significant Ki-67 expression.", "population_specificity": "A 79-year-old man with choroidal melanoma treated 15 years earlier with iodine-125 brachytherapy.", "effective_dosage": "Not specified", "study_duration": "15 years post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:27.410806+00:00"}
{"study_id": 70435, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of V/Q SPECT and DECT in detecting residual pulmonary perfusion defects in patients with intermediate-risk pulmonary embolism.", "results_summary": "The study found that residual perfusion defects on V/Q SPECT corresponded with chronic thromboembolic disease on DECT in 66.7% of patients, while 22.1% showed hypoperfusion on DECT iodine map, and 11.1% had discordant results between the two imaging methods.", "population_specificity": "28 consecutive patients (13 men, 15 women, mean age 60) with intermediate-risk pulmonary embolism.", "effective_dosage": "Not specified", "study_duration": "Six months after diagnosis", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:27.979465+00:00"}
{"study_id": 70437, "supplement_id": 1234, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of 2.5% povidone-iodine ophthalmic solution versus 1% chloramphenicol eye ointment in reducing bacterial colonies in neonatal conjunctivae.", "results_summary": "The 2.5% povidone-iodine solution was equally effective as 1% chloramphenicol in reducing bacterial colonies, with no reported adverse effects like toxic conjunctivitis or corneal haziness.", "population_specificity": "Newborns (neonates)", "effective_dosage": "2.5% povidone-iodine ophthalmic solution (single application)", "study_duration": "2 hours post-prophylaxis", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:29.150317+00:00"}
{"study_id": 70439, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the diagnostic accuracy of 18F-FDG PET/CT and 131I-MIBG scintigraphy in pediatric neuroblastoma patients.", "results_summary": "18F-FDG PET/CT showed higher accuracy and detected more lesions than 131I-MIBG scintigraphy, particularly for lymph node and bone/bone marrow lesions, though no significant difference was found for primary lesions.", "population_specificity": "Pediatric patients (age 5.5 \u00b1 5.6 years) with histopathologically proven neuroblastoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:31.157239+00:00"}
{"study_id": 70440, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to formulate radiation precautions for Graves' disease patients undergoing (131)I therapy by measuring actual biokinetics and dose rates.", "results_summary": "The study found high variability in (131)I biokinetics among patients, with thyroid uptake ranging from 18%-89% and effective half-lives in the body ranging from 3.5-7.2 hours. Detailed radiation safety instructions were provided based on these measurements.", "population_specificity": "Graves' disease patients preparing for (131)I therapy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:31.438502+00:00"}
{"study_id": 70442, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of multiple kinase inhibitors (MKIs) in treating advanced differentiated thyroid cancer (DTC) refractory to radioactive iodine.", "results_summary": "The study highlights promising results from MKIs like sorafenib and lenvatinib in treating advanced DTC, showing improved progression-free survival and response rates compared to traditional therapies.", "population_specificity": "Patients with locally recurrent, progressive, or metastatic DTC refractory to radioactive iodine treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:34.035265+00:00"}
{"study_id": 70441, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the causes, diagnosis, and treatment options for hyperthyroidism in children, with a focus on Graves' disease and the role of radioactive iodine.", "results_summary": "The study found that Graves' disease is the most common cause of hyperthyroidism in children, diagnosed via thyroid function tests and antibody measurements. Treatment options include antithyroid medications, radioactive iodine, and surgery, with methimazole preferred over propylthiouracil due to safety concerns.", "population_specificity": "Children with hyperthyroidism, including neonatal cases from mothers with Graves' disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:34.209902+00:00"}
{"study_id": 70444, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of BRAF(V600E) mutations in thyroid cancer, particularly its correlation with aggressive, iodine-resistant phenotypes and potential therapeutic targets.", "results_summary": "The study found that BRAF(V600E) mutations are linked to more aggressive and iodine-resistant thyroid cancers, suggesting their prognostic value and potential as targets for novel drug development.", "population_specificity": "Patients with papillary thyroid cancer (PTC) and papillary-derived anaplastic thyroid cancer (ATC).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:34.574304+00:00"}
{"study_id": 70445, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the importance of iodine prophylaxis and the management of thyroid diseases during pregnancy to mitigate adverse effects on maternal and fetal health.", "results_summary": "The study concluded that iodine prophylaxis should be systematically administered during pregnancy to prevent thyroid dysfunction, which can significantly impact maternal and fetal health. Guidelines for high-risk individuals were reviewed, though universal screening remains unsupported by high-evidence studies.", "population_specificity": "Pregnant women, particularly those at high risk for thyroid diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:35.467519+00:00"}
{"study_id": 70443, "supplement_id": 1234, "safety_score": "80", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of povidone-iodine pleurodesis for treating refractory chylothorax in newborn infants unresponsive to conservative treatment.", "results_summary": "Four out of five patients achieved resolution of pleural effusion with a single povidone-iodine infusion, with a median resolution time of 4 days. No long-term side effects were reported, though one patient with severe thrombosis did not benefit.", "population_specificity": "Newborn infants with persistent chylothorax unresponsive to conservative treatment.", "effective_dosage": "2 ml/kg of a 4% povidone-iodine solution, administered once.", "study_duration": "Single intervention with 4-hour pleural tube clamping.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:35.750371+00:00"}
{"study_id": 70446, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether subgingival rinsing with 10% PVP-iodine during instrumentation reduces the prevalence and magnitude of bacteraemia of oral origin in patients with periodontitis.", "results_summary": "The study found that PVP-iodine rinsing significantly reduced bacteraemia (2/19 cases vs. 10/19 in controls) and bacterial load (3.0 CFU vs. 12.2 CFU). Anaerobic bacteria were not detected in the test group.", "population_specificity": "Patients with periodontitis undergoing subgingival instrumentation.", "effective_dosage": "10% PVP-iodine, gargled for 1 minute and subgingivally rinsed for 1 minute.", "study_duration": "Single intervention session.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:38.183973+00:00"}
{"study_id": 70447, "supplement_id": 1234, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of Povidone-iodine Pleurodesis (PIP) with Talc Powder Pleurodesis (TPP) for treating recurrent malignant pleural effusion.", "results_summary": "PIP showed comparable efficacy to TPP in achieving symptomatic relief and preventing recurrence of pleural effusion, with similar post-procedure complications and hospital stays. Both treatments were well-tolerated with no significant differences in adverse events.", "population_specificity": "39 neoplastic patients (11 males, 28 females) with recurrent malignant pleural effusion, mean age ~71 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:39.780215+00:00"}
{"study_id": 70450, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether acetylcysteine could prevent contrast-induced nephropathy associated with iodine-containing contrast solutions.", "results_summary": "The study found that acetylcysteine does not reduce the need for dialysis, mortality, or other important outcomes, despite not causing significant adverse effects.", "population_specificity": "Patients undergoing diagnostic or therapeutic procedures requiring iodine-containing contrast solutions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:41.156228+00:00"}
{"study_id": 70451, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the antiseptic effects of aqueous and alcoholic povidone-iodine solutions in preventing cardiac implantable electronic device (CIED) infections and identify predictive factors for such infections.", "results_summary": "The study found no significant difference in infection rates between aqueous (2.2%) and alcoholic (2.7%) povidone-iodine solutions. Independent predictors of CIED infection included re-intervention, hematoma, and the number of generator replacements.", "population_specificity": "Patients undergoing cardiac implantable electronic device implantation (1326 patients).", "effective_dosage": "Not specified", "study_duration": "1-year periods for each solution (total 2 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:42.596464+00:00"}
{"study_id": 70448, "supplement_id": 1234, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers examined the effects of iodine-rich amiodarone on thyroid function, focusing on mechanisms and treatments for amiodarone-induced thyroid dysfunction (hypothyroidism and thyrotoxicosis).", "results_summary": "Amiodarone causes thyroid dysfunction (15-20% of cases), including hypothyroidism (AIH) and thyrotoxicosis (AIT), with distinct types (1 and 2) requiring different treatments. Type 1 AIT responds poorly to thioamides due to iodine saturation, while type 2 AIT is best treated with glucocorticoids. Mixed forms may need combined therapy, and surgery is an option for resistant cases.", "population_specificity": "Patients treated with amiodarone (iodine-rich antiarrhythmic drug).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Thioamides, sodium/potassium perchlorate, glucocorticoids, and potential interference with radioiodine treatment due to iodine load.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:42.640073+00:00"}
{"study_id": 70449, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether povidone iodine ointment (PIO) could inactivate vaccinia virus (VACV) shedding from smallpox vaccination sites without affecting immune response.", "results_summary": "PIO significantly reduced viral shedding levels and duration compared to controls, without altering immune response metrics like neutralizing antibodies, IgM, IgG, or interferon-gamma. At least 10% of control subjects continued shedding VACV at day 28, while PIO reduced shedding from day 8 until days 21-23.", "population_specificity": "60 individuals scheduled to receive smallpox vaccine (30 control, 30 treatment).", "effective_dosage": "Not specified (application started on post-vaccination day 7).", "study_duration": "Until viral shedding ceased (median 14.5 days for PIO group, 21 days for controls).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:44.410140+00:00"}
{"study_id": 70452, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review advances in the epidemiology and etiology of non-autoimmune hypothyroidism, with a focus on thyroid dysfunction in preterm infants, including the role of iodine supply (excess/deficiency).", "results_summary": "The study highlights that iodine supply (excess or deficiency) is among environmental factors contributing to the increased incidence of hypothyroidism, alongside other factors like thyroid-disrupting chemicals and drugs interfering with thyroid function. No specific efficacy or safety outcomes related to iodine were detailed.", "population_specificity": "Preterm infants, newborns (including low birth weight and very low birth weight infants), and children with syndromic forms (e.g., Williams, Down, Turner syndromes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Drugs interfering with thyroid function were mentioned, but no specific interactions with iodine were detailed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:44.524113+00:00"}
{"study_id": 70453, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess whether iodine-impregnated adhesive drapes reduce surgical site infection rates compared to no drapes.", "results_summary": "The study found no significant effect of iodine-impregnated adhesive drapes on surgical site infection rates (RR 1.03, 95% CI 0.06 to 1.66, P = 0.89). Length of hospital stay was similar between groups.", "population_specificity": "Patients undergoing any type of surgery (3082 participants in adhesive drape vs. no drape comparison; 1113 in iodine-impregnated drape vs. no drape comparison).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:45.065904+00:00"}
{"study_id": 70454, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop guidelines for the evaluation and management of thyroid nodules and differentiated thyroid cancer (DTC) in children and adolescents, addressing unique considerations compared to adults.", "results_summary": "The study provided recommendations for diagnostic approaches (e.g., ultrasound, fine-needle aspiration) and treatment strategies (e.g., surgical management, radioactive iodine therapy) tailored to pediatric patients, emphasizing the need for less aggressive treatment due to higher risks of long-term harm.", "population_specificity": "Children and adolescents (\u226418 years) with thyroid nodules or differentiated thyroid cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:46.991277+00:00"}
{"study_id": 70455, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of hemodialysis on the removal of certoparin and compare its pharmacokinetics with other low-molecular weight heparins (LMWHs) and unfractionated heparin (UFH).", "results_summary": "The study found that certoparin does not accumulate in dialysis patients, has a short plasma half-life (2.0 \u00b1 0.7 h), and minimal elimination into dialysate (2.7%). In vitro experiments showed low adsorption (6%) onto dialysis membranes and minimal sieving coefficients (\u22640.1) for certoparin and enoxaparin.", "population_specificity": "12 maintenance hemodialysis patients (subgroup of the MEMBRANE study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:48.430802+00:00"}
{"study_id": 70456, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "To determine whether preoperative skin antisepsis with iodine or other antiseptics prevents surgical site infections (SSIs) and to compare the effectiveness of different antiseptics.", "results_summary": "One study suggested 0.5% chlorhexidine in methylated spirits reduced SSI risk compared to alcohol-based povidone iodine, but evidence quality was low. No other significant differences were found between iodine-containing products and other antiseptics.", "population_specificity": "Patients undergoing clean surgery (2,623 participants across 13 studies).", "effective_dosage": "Not specified (concentration of povidone iodine not reported).", "study_duration": "Preoperative application (single use before surgery).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:50.186669+00:00"}
{"study_id": 70457, "supplement_id": 1234, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the five-year biochemical control, toxicity profile, and dosimetric parameters of iodine-125 low dose rate brachytherapy as monotherapy for early-stage prostate cancer.", "results_summary": "The study found excellent five-year biochemical control (7% failure rate) with low toxicities, though some adverse effects like incontinence and acute proctitis were reported. Quality of life aspects were favorable, and a learning curve was detected for procedural aspects.", "population_specificity": "169 men with early-stage prostate cancer.", "effective_dosage": "Not specified (low dose rate brachytherapy).", "study_duration": "Medium follow-up time was 50 months (range, 1-85 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:52.826729+00:00"}
{"study_id": 70458, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether 10% povidone iodine (PVPI) as a cooling liquid during full-mouth ultrasonic debridement (FMUD) provided additional clinical, immunological, or microbiological benefits compared to saline solution in treating generalized aggressive periodontitis (GAgP).", "results_summary": "The study found that FMUD with PVPI reduced Aa levels in deep pockets but showed no significant differences in clinical, immunological, or microbiological outcomes compared to saline solution. Both treatments improved periodontal parameters, but PVPI did not enhance overall therapy results.", "population_specificity": "28 patients with generalized aggressive periodontitis (GAgP).", "effective_dosage": "10% PVPI solution used as a cooling agent during FMUD.", "study_duration": "Evaluations were conducted at baseline, first, third, and sixth months post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:53.577741+00:00"}
{"study_id": 70460, "supplement_id": 1234, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether thiamazole (MTZ) pretreatment could enhance the therapeutic efficacy of radioiodine (131I) in patients with multinodular goiter and low radioiodine uptake.", "results_summary": "MTZ pretreatment significantly increased 24-hour radioiodine uptake (RAIU) by an average of 2-fold, reduced the required therapeutic (131I) activity by 31%, and improved thyroid function parameters without significant changes in thyroid volume. No significant changes were observed in the low-iodine diet (LID) group.", "population_specificity": "22 patients with multinodular goiter, subclinical hyperthyroidism, and RAIU < 50%.", "effective_dosage": "MTZ 30 mg/day.", "study_duration": "42 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:53.600436+00:00"}
{"study_id": 70459, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of I-131 MIBG therapy in treating neuroblastoma, particularly in refractory, relapsed, and newly diagnosed cases, and explore its combination with other therapies.", "results_summary": "Low-dose I-131 MIBG monotherapy showed high pain reduction but poor objective response, while higher doses (\u226512 mCi/kg) with or without hematopoietic cell transplantation yielded better responses in refractory/relapsed cases. Combination therapies with chemotherapy and HCT improved outcomes, and incorporating I-131 MIBG into induction therapy was feasible for newly diagnosed patients.", "population_specificity": "Patients with neuroblastoma, including refractory, relapsed, and newly diagnosed cases.", "effective_dosage": "\u226512 mCi/kg I-131 MIBG (higher doses), unspecified for low-dose monotherapy.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:54.307478+00:00"}
{"study_id": 70461, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of sialendoscopy in treating radioactive iodine-induced sialadenitis (RAIS) and xerostomia in patients who did not respond to conservative management.", "results_summary": "Sialendoscopy showed significant improvement in symptoms, with 64% of patients reporting complete resolution of RAIS and 31.8% reporting complete resolution of xerostomia. Statistical analysis confirmed a significant increase in unstimulated saliva production at 6 months post-intervention.", "population_specificity": "26 patients (24 women, 2 men; median age 43 years) with RAIS and xerostomia refractory to conservative therapy.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 23.4\u00b112.1 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:54.309373+00:00"}
{"study_id": 70462, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of thyroid dysfunction, including iodine insufficiency, on fertility and pregnancy outcomes, and assess the validity of levothyroxine treatment in thyroid autoimmunity-positive women.", "results_summary": "The study found that thyroid dysfunction, including iodine insufficiency, can adversely affect fertility and pregnancy outcomes, such as miscarriage and preterm delivery. Levothyroxine may reduce these risks in thyroid autoimmunity-positive women, but further research is needed.", "population_specificity": "Pregnant women and women of childbearing age, particularly those undergoing in vitro fertilization.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:54.949197+00:00"}
{"study_id": 70463, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the diagnostic accuracy of Visual Inspection with Lugol\u2019s Iodine (VILI) and Visual Inspection with Acetic Acid (VIA) for detecting cervical intraepithelial neoplasia 2 or greater (CIN2+) among HIV-infected women.", "results_summary": "VILI and VIA showed similar diagnostic accuracy for detecting CIN2+, with no significant differences in sensitivity or specificity. However, VILI had significantly decreased specificity in women with CD4+ counts < 350 compared to VIA in the same group and to VILI in women with CD4+ counts \u2265 350.", "population_specificity": "HIV-infected women attending the Family AIDS Care and Education Services (FACES) clinic in western Kenya.", "effective_dosage": "Not specified", "study_duration": "October 2011 to June 2012 (approximately 8 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:57.666810+00:00"}
{"study_id": 70464, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the long-term outcomes of charged particle radiation therapy (CPT) versus iodine-125 plaque therapy for treating choroidal and ciliary body melanoma.", "results_summary": "Particle therapy showed significantly improved local control (98% vs. 79% at 12 years), higher eye preservation rates (17% vs. 37% enucleation at 12 years), and prolonged disease-free survival compared to iodine-125 plaque therapy.", "population_specificity": "Patients with choroidal and ciliary body melanoma, stratified by tumor characteristics and visual acuity.", "effective_dosage": "Not specified", "study_duration": "Median follow-up times were 14.6 years for particle therapy and 12.3 years for plaque therapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:14:59.109520+00:00"}
{"study_id": 70466, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to identify gaps in knowledge regarding the nutritional values of Nigerian ethnic diets, including iodine deficiency disorder (IDD).", "results_summary": "The abstract highlights the prevalence of iodine deficiency disorder (IDD) among other malnutrition types in Nigeria but does not provide specific findings on iodine's effects.", "population_specificity": "Nigerian population, with focus on ethnic groups (Yorubas, Igbos, Hausas, Fulanis).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:01.389241+00:00"}
{"study_id": 70465, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to calculate and compare dose rates from iodine-131 exposure in medical therapy scenarios, considering tissue attenuation and biokinetics, to improve external dose rate estimates.", "results_summary": "The study found that dose rates varied based on patient uptake (hyperthyroid cases had the highest, DTC the lowest) and exposure scenarios (e.g., seated behind a patient on public transport yielded the highest dose rate). The method provided detailed estimates for different scenarios, highlighting the importance of case-specific factors.", "population_specificity": "Patients treated with iodine-131 (normal thyroid uptake, differentiated thyroid cancer, hyperthyroidism) and members of the public exposed to them.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:01.391625+00:00"}
{"study_id": 70468, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate treatment options for differentiated thyroid cancer, emphasizing a risk-benefit approach tailored to individual factors, particularly in older individuals.", "results_summary": "The study advocates for a multidisciplinary, risk-benefit approach to thyroid cancer care, balancing treatment success likelihood with adverse effects, especially in elderly patients with aggressive disease.", "population_specificity": "Patients with differentiated thyroid cancer, particularly older individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:01.619690+00:00"}
{"study_id": 70467, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers evaluated the impact of FDG-PET/CT on clinical management and prognostic implications in iodine-refractory differentiated thyroid cancer.", "results_summary": "FDG-PET/CT altered management in 14% to 78% of patients with suspected recurrence, and a positive scan was linked to poorer survival. Similar findings were noted for anaplastic and medullary thyroid cancers, though based on fewer studies.", "population_specificity": "Patients with iodine-refractory differentiated thyroid cancer, anaplastic thyroid cancer, and medullary thyroid cancer.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:01.842285+00:00"}
{"study_id": 70470, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to review recent findings on the Na(+)/I(-) symporter (NIS) and its role in iodine absorption, metabolism, and homeostasis, as well as its potential applications in disease imaging and treatment.", "results_summary": "The study highlights NIS as a key component in iodine absorption and metabolism, with findings on its structure, function, and regulatory mechanisms, including autoregulatory effects of intracellular iodine levels on NIS activity. It also discusses progress in using NIS for medical imaging and therapeutic applications.", "population_specificity": "Not specified (focus on molecular and cellular mechanisms in vertebrates).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:03.213292+00:00"}
{"study_id": 70469, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers evaluated the impact of pretreatment vitamin D levels on follicular lymphoma (FL) outcomes, comparing outcomes between patients treated with rituximab or iodine-131 tositumomab.", "results_summary": "The study found that vitamin D deficiency was associated with worse progression-free and overall survival in FL patients, though statistical significance was not reached in one cohort. The results suggest a potential link between low vitamin D levels and poorer FL outcomes.", "population_specificity": "Previously untreated patients with follicular lymphoma enrolled in SWOG clinical trials (1998-2008) or the LYSA PRIMA trial (2004-2007).", "effective_dosage": "Not specified for iodine-131 tositumomab.", "study_duration": "Median follow-up of 5.4 years (SWOG cohort) and 6.6 years (LYSA cohort).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:05.276378+00:00"}
{"study_id": 70471, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether salivary stimulation therapy with pilocarpine could alleviate symptoms and restore function in patients with chronic radioactive iodine (RAI)-induced sialadenitis.", "results_summary": "The study found that pilocarpine therapy significantly improved subjective symptoms but did not significantly restore salivary gland function, as measured by salivary flow rates and scintigraphy parameters.", "population_specificity": "61 patients with chronic RAI-induced sialadenitis after thyroidectomy and RAI therapy.", "effective_dosage": "5 mg pilocarpine, 3 times daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:06.147746+00:00"}
{"study_id": 70472, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential role of SPECT-CT, including the use of (131)Iodine and (123)Iodine, in optimizing tumor target definition in radiotherapy for differentiated thyroid cancer (DTC).", "results_summary": "The study suggests that SPECT-CT, particularly with (131)Iodine and (123)Iodine, can improve the delineation of Gross Tumor Volume (GTV) and Clinical Target Volume (CTV) in DTC, potentially enhancing radiotherapy precision and sparing normal tissue. The abstract highlights the utility of these radiopharmaceuticals in oncology but does not provide specific efficacy data.", "population_specificity": "Patients with differentiated thyroid cancer (DTC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:07.382286+00:00"}
{"study_id": 70474, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were evaluating the development and approval of lenvatinib for treating radioactive iodine-refractory differentiated thyroid cancer and other malignancies.", "results_summary": "The abstract summarizes the milestones in lenvatinib's development, including its approval for radioactive iodine-refractory differentiated thyroid cancer and ongoing phase 3 trials for other indications. It does not provide specific results about iodine's effects.", "population_specificity": "Patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:08.959724+00:00"}
{"study_id": 70473, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the pathophysiology and clinical features of TSH resistance due to inactivating TSHR mutations, with a focus on the nonclassic form.", "results_summary": "The study found that TSH resistance caused by TSHR mutations leads to defective thyroid hormone production, with phenotypes varying based on residual receptor activity, including severe hypothyroidism or preserved hormone production. A newly identified nonclassic form shows paradoxically high thyroidal iodine uptake.", "population_specificity": "Individuals with congenital hypothyroidism due to inactivating TSHR mutations.", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:08.989995+00:00"}
{"study_id": 70476, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the indications, techniques, and post-procedural imaging appearances of pleurodesis, including the use of povidone iodine as a chemical agent.", "results_summary": "The abstract does not provide specific results regarding iodine's effects, only mentioning its use as one of several substances for chemical pleurodesis.", "population_specificity": "Not specified (general discussion of pleurodesis procedures).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:09.480345+00:00"}
{"study_id": 70475, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether low-dose radioactive iodine (RAI) is noninferior to high-dose RAI for ablation in nonmetastatic differentiated thyroid cancer patients with macroscopic extrathyroidal extension (MAEE) and low preablative-stimulated thyroglobulin (ps-Tg).", "results_summary": "The study found no significant difference in ablation success rates (84.3% vs. 86.27%) or clinical recurrence between low-dose (1110 MBq) and high-dose (3700 MBq) RAI groups, demonstrating noninferiority of low-dose RAI in this patient population.", "population_specificity": "Differentiated thyroid cancer patients with complete thyroidal resection, MAEE, any N stage, ps-Tg \u22645 ng/ml, and no distant metastasis.", "effective_dosage": "1110 MBq (low-dose) or 3700 MBq (high-dose), single administration.", "study_duration": "Follow-up at 6 months post-ablation (mean follow-up 6.8 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:11.799393+00:00"}
{"study_id": 70478, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to assess the efficacy and safety of different interventions, including iodine-based diagnostic tests, for treating Frey's syndrome.", "results_summary": "The study found no RCTs or quasi-RCTs meeting inclusion criteria, making it impossible to establish the efficacy or safety of treatments like iodine-based diagnostic methods for Frey's syndrome.", "population_specificity": "Patients diagnosed with Frey's syndrome using clinical standards like Minor's starch-iodine test.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:12.126819+00:00"}
{"study_id": 70477, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the limitations of radioactive iodine (RAI) in treating thyroid cancer and explore the need for new targeted therapies.", "results_summary": "The study highlights that while RAI is standard for thyroid cancer, 5% of patients develop metastatic disease unresponsive to RAI, necessitating novel targeted therapies like sorafenib. It identifies key genetic pathways involved in thyroid cancer progression.", "population_specificity": "Patients with thyroid cancer, particularly those with metastatic or RAI-refractory disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:12.511233+00:00"}
{"study_id": 70480, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the importance of iodine and other micronutrients during pregnancy, particularly in Low- and Middle-Income Countries (LMIC), and their impact on fetal and neonatal development.", "results_summary": "The study recognized iodine as crucial for fetal and neonatal development, highlighting its role alongside other micronutrients like iron and calcium. Deficiencies in iodine and other micronutrients were noted to have significant impacts on reproductive outcomes, emphasizing the need for improved supplementation and fortification programs.", "population_specificity": "Pregnant women, particularly in Low- and Middle-Income Countries (LMIC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:15.594852+00:00"}
{"study_id": 70479, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the bactericidal activity of povidone iodine (P) and other antiseptics under adapted trial conditions for use in gynecology and dermatology.", "results_summary": "Povidone iodine (P) was not bactericidal on E. hirae at any concentration and on S. aureus at 97% concentration, indicating limited efficacy under the tested conditions. The study found that only the chlorhexidine-benzalkonium (CB) combination showed consistent bactericidal activity across multiple strains and concentrations.", "population_specificity": "In vitro bacterial strains (P. aeruginosa, E. hirae, S. aureus, and others as per NF EN 13727 standard).", "effective_dosage": "Concentrations tested: 97% (pure solution), 50%, 10%, and 1%.", "study_duration": "60 seconds of contact time.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:15.666348+00:00"}
{"study_id": 70482, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of sorafenib in treating radioactive iodine (RAI)-refractory differentiated thyroid carcinoma (DTC).", "results_summary": "Sorafenib significantly prolonged median progression-free survival (PFS) compared to placebo in patients with RAI-refractory DTC, with a higher objective response rate. However, overall survival benefits were unclear, and adverse events led to high rates of therapy discontinuation or dose adjustments.", "population_specificity": "Patients with RAI-refractory, locally advanced or metastatic differentiated thyroid carcinoma.", "effective_dosage": "400 mg twice daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:16.639391+00:00"}
{"study_id": 70481, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of iodine-based antiseptic preparations (e.g., povidone-iodine) against chlorhexidine-based solutions in reducing surgical site infections (SSIs).", "results_summary": "The study found that chlorhexidine-isopropyl alcohol was superior to povidone-iodine in reducing SSIs, particularly in clean-contaminated surgery. However, smaller RCTs showed mixed results, and non-randomized studies generally found no significant differences between antiseptic agents.", "population_specificity": "Patients undergoing surgical procedures, particularly clean-contaminated surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:17.279277+00:00"}
{"study_id": 70483, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a preoperative decontamination protocol using intranasal povidone-iodine could reduce surgical site infections (SSIs) in patients undergoing elective orthopedic surgery with hardware implantation.", "results_summary": "The study found that the decontamination protocol, including intranasal povidone-iodine, significantly reduced SSI rates from 3.8% in the control group to 1.1% in the intervention group, demonstrating a more than 50% reduction. Multivariate analysis confirmed the protocol as an independent predictor of reduced SSI risk.", "population_specificity": "Patients undergoing elective orthopedic surgery with hardware implantation at a Veterans Affairs Medical Center.", "effective_dosage": "Nasal povidone-iodine solution used the night before and the morning of surgery (specific concentration not stated).", "study_duration": "Single preoperative application (night before and morning of surgery).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:19.071042+00:00"}
{"study_id": 70486, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were not studying Iodine; the abstract focuses on dual-energy MDCT applications for imaging renal masses.", "results_summary": "The study found that dual-energy MDCT improves radiologists' ability to diagnose renal masses compared to conventional MDCT, potentially enhancing clinical management.", "population_specificity": "Not specified (abstract does not mention a specific population).", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:19.329499+00:00"}
{"study_id": 70484, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to review novel approaches for imaging and treating radioactive iodine (RAI)-refractory thyroid cancer, focusing on targeting the tumor microenvironment.", "results_summary": "The study highlights the limitations of current radiopharmaceuticals for RAI-refractory thyroid cancer and discusses emerging markers in the tumor microenvironment as potential targets for improved diagnosis and therapy.", "population_specificity": "Patients with poorly differentiated thyroid cancer (PDTC) and undifferentiated thyroid cancer (UDTC), particularly those with RAI-refractory metastases or recurrences.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:19.772906+00:00"}
{"study_id": 70485, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if povidone-iodine (PVP-I)-based nasal antiseptic (SNP) could effectively reduce MRSA bioburden in nasal and skin explants and human subjects compared to mupirocin and saline.", "results_summary": "SNP significantly reduced MRSA in porcine mucosal and human skin explants (>2.0 log10 CFU reduction) and in human nares compared to saline, regardless of mupirocin sensitivity. Pretreatment with SNP also prevented MRSA infection in explants.", "population_specificity": "Porcine mucosal and human skin explants, and human subjects (anterior nares).", "effective_dosage": "Two consecutive applications of SNP (specific dosage not detailed).", "study_duration": "Effects measured at 1, 6, and 12 hours post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:21.818585+00:00"}
{"study_id": 70488, "supplement_id": 1234, "safety_score": "10", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers reviewed the chemical properties and toxic effects of krokodil, including the role of iodine in its synthesis.", "results_summary": "The study did not assess iodine's safety or efficacy directly but noted its use as a starting material in the synthesis of desomorphine, a component of krokodil. The toxic effects described were attributed to byproducts of the homemade synthesis process, not iodine itself.", "population_specificity": "Not specified (review of existing literature on krokodil use).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:22.736710+00:00"}
{"study_id": 70489, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the variation in biopsy Gleason grading between local and central pathologists in prostate cancer cases, not specifically related to iodine.", "results_summary": "The study found a 65.3% exact concordance rate in Gleason scores between local and central pathologists, with under-grading at 14.6% and over-grading at 20.1%. Central review also reassigned tumor-bearing cores in 16.1% of cases.", "population_specificity": "Patients with intermediate-risk prostate cancer from 18 Japanese institutions.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:24.164826+00:00"}
{"study_id": 70487, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of radioiodine (RAI) as a potential first-line therapy for paediatric Graves' disease and identify predictors of remission after antithyroid drug (ATD) therapy.", "results_summary": "The study found that most patients (8 out of 9) relapsed after a 2-year course of carbimazole, with a mean relapse duration of 0.82 years. RAI was used in some cases due to intolerance or contraindications to other treatments, suggesting it may be considered as an alternative first-line therapy in specific cases.", "population_specificity": "Paediatric patients (ages 7.2-17.1 years) diagnosed with Graves' disease.", "effective_dosage": "Not specified", "study_duration": "2 years for carbimazole treatment; follow-up duration varied.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:25.446711+00:00"}
{"study_id": 70490, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of Radioactive Seed Localization (RSL) using iodine-125 and Radioguided Occult Lesion Localization (ROLL) using 99mTechnetium colloid for guiding breast-conserving surgery in non-palpable breast cancer.", "results_summary": "The study found that RSL and ROLL had comparable positive margin rates and re-excision rates, but RSL resulted in significantly lower specimen weight for DCIS lesions, suggesting more precise localization. The researchers favored RSL due to its logistical convenience and better position verification.", "population_specificity": "Patients with unifocal non-palpable ductal carcinoma in situ (DCIS) or invasive carcinoma undergoing breast-conserving surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:26.871999+00:00"}
{"study_id": 70491, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of acupuncture for treating radioactive iodine (RAI)-induced anorexia in thyroid cancer patients.", "results_summary": "True acupuncture showed higher but statistically insignificant improvements in anorexia scores compared to sham acupuncture. Significant differences were found in some quality-of-life measures (TOI, FACT-G, FAACT scores), but no differences were observed in VAS, weight, BMI, ACTH, or cortisol levels.", "population_specificity": "Thyroid cancer patients with RAI-induced anorexia (n=14).", "effective_dosage": "6 acupuncture treatments (true or sham) over 2 weeks.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:27.041826+00:00"}
{"study_id": 70492, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers reviewed the use of radionuclides, including iodine-124, for tumor imaging and therapy, focusing on advancements in antibody targeting and pretargeting strategies.", "results_summary": "The study highlights iodine-124 as a promising radionuclide for immuno-specific tumor imaging, particularly in PET imaging, due to its long half-life, alongside other radionuclides like zirconium-89. New antibody analogues and pretargeting strategies have improved tumor immunotargeting, renewing interest in these approaches for personalized medicine.", "population_specificity": "Not specified (general review of radionuclide applications in cancer imaging and therapy).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:27.245211+00:00"}
{"study_id": 70493, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of lenvatinib compared to placebo in patients with progressive, iodine-131-refractory thyroid cancer.", "results_summary": "Lenvatinib significantly improved progression-free survival (18.3 vs. 3.6 months) and response rates (64.8% vs. 1.5%) compared to placebo, but was associated with frequent adverse effects, including hypertension, diarrhea, and fatigue.", "population_specificity": "Patients with progressive, iodine-131-refractory thyroid cancer.", "effective_dosage": "24 mg per day in 28-day cycles.", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:27.862033+00:00"}
{"study_id": 70494, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the epidemiology and molecular mechanisms of maternal hypothyroxinemia, particularly its link to iodine deficiency and its impact on fetal neurodevelopment.", "results_summary": "Maternal hypothyroxinemia, often caused by mild iodine deficiency, leads to neurodevelopmental impairments in offspring, including cognitive deficits and poor psychomotor development. Rodent models confirmed these effects, showing structural and functional neural abnormalities.", "population_specificity": "Pregnant women and their developing fetuses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:28.874212+00:00"}
{"study_id": 70495, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the development and clinical use of sorafenib for treating advanced radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC).", "results_summary": "Sorafenib significantly improves progression-free survival in metastatic DTC patients who are RAI-refractory, though overall survival benefits remain unproven. The drug has a significant side-effect profile, often requiring dose reductions.", "population_specificity": "Patients with advanced RAI-refractory differentiated thyroid cancer (DTC).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:30.164818+00:00"}
{"study_id": 70496, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine if sentinel lymph node biopsy (SLNB) using radioisotopes could detect occult metastasis in papillary thyroid carcinoma (PTC) and prevent recurrence.", "results_summary": "The study found that while SLNB detected occult metastases in 30% of cases, it did not significantly affect stimulated thyroglobulin levels or recurrence rates after a median follow-up of 39 months.", "population_specificity": "283 patients with papillary thyroid carcinoma (PTC) treated at Samsung Medical Center.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 39 months (range 7-55 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:31.729835+00:00"}
{"study_id": 70497, "supplement_id": 1234, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers examined the case of an elderly patient with symptomatic primary hyperparathyroidism (PHPT) and incidental pulmonary embolism, focusing on complications related to iodine exposure and transient thyrotoxicosis post-surgery.", "results_summary": "The study reported transient thyrotoxicosis likely induced by iodine load or thyroid surgical manipulation, managed with beta-blockers. It also noted transient hypercortisolism related to PHPT stress, resolved post-surgery.", "population_specificity": "Elderly patient with symptomatic PHPT and incidental pulmonary embolism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:33.100974+00:00"}
{"study_id": 19343, "supplement_id": 1252, "safety_score": "40", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of S-ketamine anesthesia on thyroid hormone levels and myelination in neonatal rats, and whether T3 supplementation could mitigate these effects.", "results_summary": "S-ketamine anesthesia significantly decreased thyroid hormones and impaired myelination and motor coordination in neonatal rats. T3 supplementation reversed these effects via the PPAR\u03b1 signaling pathway, and PPAR\u03b1 activation with fenofibrate also rescued deficits.", "population_specificity": "Neonatal rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:39.993361+00:00"}
{"study_id": 19345, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of ketamine versus ECT for treatment-resistant depression and guide clinicians in choosing the optimal treatment.", "results_summary": "The study found that ketamine may be a promising alternative to ECT for treatment-resistant depression, with two noninferiority trials and three meta-analyses supporting its efficacy, though results on superiority were contradictory. The authors highlighted variations in study design and patient factors as potential reasons for discrepancies.", "population_specificity": "Patients with moderate to severe treatment-resistant depression.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:40.898751+00:00"}
{"study_id": 19344, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of ketamine as a rapid-acting antidepressant for treatment-resistant unipolar depression.", "results_summary": "Ketamine significantly reduced depressive symptoms and suicidal ideation within hours, with effects lasting up to 1 week, but common side effects included transient dissociation, elevated blood pressure, nausea, and dizziness. Long-term safety remains uncertain.", "population_specificity": "Individuals with formally diagnosed unipolar depression, particularly treatment-resistant cases.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Effects observed within hours, lasting up to 1 week (intervention duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:41.808655+00:00"}
{"study_id": 19342, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of adjunctive ketamine versus buprenorphine in reducing anxiety symptoms and opioid cravings in individuals with co-occurring major depressive disorder (MDD) and opioid use disorder (OUD).", "results_summary": "Ketamine showed rapid and substantial reductions in anxiety symptom severity within hours of administration, along with a pronounced decline in opioid craving intensity. These effects were more immediate compared to buprenorphine, which exhibited gradual but sustained improvements.", "population_specificity": "Individuals diagnosed with both MDD and OUD.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Assessments were conducted at 2 hours, 24 hours, and 7 days post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:41.865156+00:00"}
{"study_id": 19340, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanistic role of the opioid system in ketamine's effects on functional brain connectivity and whether these effects differ by biological sex.", "results_summary": "Ketamine-induced functional connectivity changes were modulated by opioid receptor blockade (naltrexone), with sex-dependent effects observed in the medial prefrontal cortex (mPFC). Male rats showed opioid-dependent increases in brain dysconnectivity and entropy, while female responses differed.", "population_specificity": "Male and female rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Naltrexone (opioid receptor antagonist) altered ketamine's effects on brain connectivity.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:41.973831+00:00"}
{"study_id": 19338, "supplement_id": 1252, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of intranasal and intravenous ketamine versus intravenous morphine for pain relief in patients with bone fractures.", "results_summary": "The study found no statistically significant difference in pain relief efficacy among intranasal ketamine, intravenous ketamine, and intravenous morphine. Intranasal ketamine showed comparable analgesic effects with minor side effects.", "population_specificity": "Patients over 18 years old presenting to the emergency department with bone fractures.", "effective_dosage": "Intranasal ketamine (1 mg/kg), intravenous ketamine (0.5 mg/kg), intravenous morphine (0.1 mg/kg).", "study_duration": "Pain severity was assessed at admission and at 15, 30, and 60 minutes post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:42.262210+00:00"}
{"study_id": 19337, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to systematically review studies evaluating the effect of ketamine and esketamine on quality of life (QoL) measures in individuals with major depressive disorder (MDD) or treatment-resistant depression (TRD).", "results_summary": "The study found statistically significant improvements in QoL measures (p < 0.001) with ketamine and esketamine treatment in adults with MDD or TRD, though the included studies had moderate risk of bias and heterogeneity in QoL scales and study durations.", "population_specificity": "Adults diagnosed with major depressive disorder (MDD) or treatment-resistant depression (TRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:42.479156+00:00"}
{"study_id": 19341, "supplement_id": 1252, "safety_score": "85", "efficacy_score": 50, "quality_score": 90, "study_goal": "The researchers aimed to compare the clinical effectiveness of paramedic-administered ketamine versus morphine for treating severe trauma pain.", "results_summary": "Ketamine did not provide superior analgesia compared to morphine, with no significant difference in efficacy or incidence of serious adverse events. Many patients still experienced pain upon hospital arrival despite treatment.", "population_specificity": "Patients aged 16+ with acute injury and a pain score \u22657 on a 0-10 NRS, excluding pregnant individuals, prisoners, and those unable to articulate pain or lacking capacity.", "effective_dosage": "Maximum available dose of ketamine was 30 mg, administered intravenously or intraosseously in small aliquots.", "study_duration": "Not specified (timing of administration was not prespecified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:42.708717+00:00"}
{"study_id": 19346, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 50, "study_goal": "The researchers aimed to determine whether intravenous ketamine could effectively lyse catatonia in a patient, potentially avoiding complications and other procedures before definitive electroconvulsive therapy.", "results_summary": "The study found that intravenous ketamine successfully lysed catatonia in the patient, allowing avoidance of potential complications and other procedures prior to electroconvulsive therapy. Further research is suggested to explore ketamine's role in treating refractory catatonia.", "population_specificity": "A patient with catatonia refractory to routine pharmacologic management.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:47.975169+00:00"}
{"study_id": 19347, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine current practice patterns, patient demographics, and barriers to accessing ketamine for psychiatric disorders, particularly treatment-resistant depression (TRD).", "results_summary": "The study found that IV ketamine was the most common administration method, with patients predominantly middle-aged (36-64 years old). Financial barriers and limited rural access were significant obstacles, and treatment protocols varied widely, highlighting the need for standardization.", "population_specificity": "Patients with psychiatric disorders, primarily treatment-resistant depression (TRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:49.620373+00:00"}
{"study_id": 19351, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 85, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness of ketamine as a second-line treatment for acute exacerbations of Stiff Person Syndrome (SPS) in patients unresponsive to conventional therapies.", "results_summary": "Ketamine provided rapid and significant symptom resolution in a refractory SPS case, though recurrent flares required repeated administration. The study highlights ketamine's potential as an adjunct therapy for acute SPS management.", "population_specificity": "A 22-year-old male with SPS diagnosed via anti-glycine receptor antibodies.", "effective_dosage": "Intravenous ketamine (specific dosage not mentioned).", "study_duration": "Duration of intervention not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:49.917604+00:00"}
{"study_id": 19350, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the preliminary efficacy of combining six ketamine infusions with written exposure therapy (WET) for reducing chronic PTSD symptoms.", "results_summary": "The combined treatment led to significant reductions in PTSD symptom severity, with 69% of patients showing \u226530% improvement, and durable effects observed in 61.5% of patients up to 6 months.", "population_specificity": "Patients with chronic PTSD and high-moderate to severe symptom levels.", "effective_dosage": "0.5 mg/kg intravenous ketamine, 3 times a week for 2 weeks.", "study_duration": "2 weeks of ketamine infusions plus 2 weeks of WET sessions, with follow-up up to 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:50.316884+00:00"}
{"study_id": 19353, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether combining ketamine with psychotherapy produces greater symptom improvement for depression and PTSD compared to ketamine alone.", "results_summary": "Both ketamine alone and ketamine plus psychotherapy showed substantial improvement in depression and PTSD symptoms, with no significant differences between the two groups. Exploratory analyses suggested potential demographic-specific treatment responses, but these were not statistically significant.", "population_specificity": "Help-seeking individuals (\u223c60% female, mean age \u223c42 years) with depression and/or PTSD.", "effective_dosage": "Not specified", "study_duration": "4-14 treatment sessions within a 30- or 180-day period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:50.381258+00:00"}
{"study_id": 19348, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 30, "study_goal": "The researchers aimed to evaluate the effects of ketamine treatments (infusion, intranasal spray, and esketamine) on a patient with treatment-resistant depression and multiple comorbid disorders over a long-term period.", "results_summary": "The patient experienced short-term benefits from ketamine infusion and electroconvulsive therapy but achieved two-year stability periods with compounded ketamine intranasal spray and esketamine, suggesting ketamine treatments may help complex TRD cases at different life stages.", "population_specificity": "A single patient with treatment-resistant depression, generalized anxiety disorder, eating disorder, post-traumatic stress disorder, and borderline personality disorder.", "effective_dosage": "Not specified", "study_duration": "Over two years for compounded ketamine intranasal spray and esketamine.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:51.541980+00:00"}
{"study_id": 19352, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antidepressant mechanisms of ketamine and its enantiomers, their clinical effectiveness and safety, and their potential role in treating depression linked to emerging viral infections.", "results_summary": "The study highlights ketamine's potent and effective antidepressant properties, particularly for treatment-resistant depression and mood complications from viral infections, but notes the need for further research on optimal strategies and long-term safety.", "population_specificity": "Patients with depression, especially treatment-resistant depression and those with mood complications linked to emerging viral infections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:51.983107+00:00"}
{"study_id": 19355, "supplement_id": 1252, "safety_score": "75", "efficacy_score": 90, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and efficacy of ketamine as a prehospital treatment for benzodiazepine-refractory status epilepticus (BRSE).", "results_summary": "Ketamine stopped seizures in 90.5% of patients, with transient hypoxia occurring in 22% and respiratory support required in some cases. The study concluded that ketamine appears safe and effective for BRSE, though respiratory monitoring is necessary.", "population_specificity": "Patients aged 8 months to 79 years treated by EMS clinicians for BRSE in an urban ground-based EMS system.", "effective_dosage": "Intramuscular average dose of 3.3 mg/kg; intravenous/intraosseous average dose of 2.2 mg/kg.", "study_duration": "Retrospective analysis from September 1, 2021, to December 1, 2023.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:52.576053+00:00"}
{"study_id": 19356, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether peripheral blood neurotrophic and inflammatory factors (NIFs) are linked to ketamine's antidepressant effects in adults with treatment-resistant depression (TRD).", "results_summary": "The study found no significant associations between ketamine treatment and peripheral NIF levels, except in individuals with lower BMI, where increased IL-1RA levels were linked to worse immediate treatment response. Overall, ketamine did not show detectable effects on NIF trajectories or their relationship with depression outcomes.", "population_specificity": "133 adults with treatment-resistant depression (TRD).", "effective_dosage": "Single-dose infusion of 0.5 mg/kg ketamine.", "study_duration": "Five-day post-infusion period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:57.473051+00:00"}
{"study_id": 19359, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether baseline opioid use influenced antidepressant responses to ketamine versus placebo in depressed surgical patients.", "results_summary": "The study found that baseline opioid use reduced depression severity in placebo recipients but not in ketamine recipients, suggesting ketamine's antidepressant effects are preserved in opioid users. The antidepressant response was independent of pain and baseline depression severity.", "population_specificity": "Depressed patients undergoing routine surgery, some on chronic opioid therapy.", "effective_dosage": "Not specified", "study_duration": "1 to 14 days post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:57.927972+00:00"}
{"study_id": 19357, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 55, "study_goal": "The researchers aimed to determine the efficacy of concurrent therapy with ECT and intravenous racemic ketamine in treatment-resistant depression (TRD).", "results_summary": "The study found no significant difference in treatment rates between the group receiving concurrent ECT and ketamine (67.31%) and the group receiving ECT alone (67.22%). Both groups showed similar remission rates, with 60% and 66.6% of patients not requiring hospitalization during follow-up.", "population_specificity": "30 patients with treatment-resistant depression, divided into two groups (one receiving ECT + ketamine, the other ECT alone).", "effective_dosage": "Not specified", "study_duration": "Follow-up periods of 6 months and 1 year after remission.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:57.957678+00:00"}
{"study_id": 19358, "supplement_id": 1252, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether adding ketamine to midazolam improves seizure cessation in pediatric generalized convulsive status epilepticus (GCSE) compared to midazolam alone.", "results_summary": "The ketamine-midazolam combination showed significantly higher seizure cessation rates at all measured timepoints (5-, 15-, 35-, and 55-minutes) and reduced the need for additional midazolam or endotracheal intubation compared to midazolam alone. No significant differences were found in other outcome measures between the two groups.", "population_specificity": "Children aged six months to 16 years with generalized convulsive status epilepticus (GCSE).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Outcomes were assessed at 5-, 15-, 35-, and 55-minute intervals, with additional 24-hour seizure control evaluation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:59.006312+00:00"}
{"study_id": 19360, "supplement_id": 1252, "safety_score": "20", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to provide a comprehensive overview of ketamine-induced cystitis, focusing on its pathophysiology, clinical presentation, diagnosis, management, and implications for addiction treatment.", "results_summary": "The study highlights ketamine-induced cystitis as a significant complication of addictive ketamine use, referencing the British Association of Urological Surgeons consensus for management and emphasizing its impact on individuals with substance use disorders.", "population_specificity": "Individuals with addictive ketamine use.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:15:59.337016+00:00"}
{"study_id": 19361, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine ketamine's effects on working memory, attention, and concentration, as well as its impact on MEG patterns during a working memory task in individuals with treatment-resistant depression (TRD).", "results_summary": "Ketamine significantly improved depressive symptoms but had no effect on cognitive performance. MEG revealed distinct gamma power changes in brain regions linked to attention and working memory after ketamine administration compared to placebo.", "population_specificity": "Twenty-one individuals with TRD (14 with bipolar disorder, 7 with major depressive disorder).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Data collected at baseline and 6 to 9 hours after ketamine and placebo infusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:02.035681+00:00"}
{"study_id": 19362, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how low-dose ketamine affects the functional connectivity of the default mode, salience, and frontoparietal networks in patients with treatment-resistant depression.", "results_summary": "The study found significant group-by-time effects on connectivity measures in key brain regions of the triple networks, suggesting ketamine may modulate these networks to exert antidepressant effects. Both ketamine and normal saline showed time effects on certain network metrics, but ketamine demonstrated specific alterations in the DMN and salience networks.", "population_specificity": "Patients with treatment-resistant depression (TRD), including those with pronounced suicidal symptoms.", "effective_dosage": "0.05 mg/kg ketamine (single infusion).", "study_duration": "Single infusion, with follow-up at Day 3.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:03.717325+00:00"}
{"study_id": 19363, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether S-ketamine reduces rebound pain and improves recovery outcomes in patients undergoing total knee arthroplasty.", "results_summary": "S-ketamine significantly reduced the incidence of rebound pain within 12 hours post-surgery (21.3% vs. 34.8%), delayed its onset, lowered pain scores, improved recovery quality, and increased patient satisfaction compared to placebo.", "population_specificity": "356 adult patients undergoing total knee arthroplasty.", "effective_dosage": "Continuous intraoperative infusion of 0.30 mg/(kg\u00b7h) from spinal anesthesia completion until joint cavity closure.", "study_duration": "From spinal anesthesia completion until joint cavity closure (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:03.912612+00:00"}
{"study_id": 19369, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore barriers and facilitators to conducting an inpatient clinical trial of ketamine infusion for treating acute pain in sickle cell disease.", "results_summary": "Clinicians showed varied comfort levels with ketamine, with barriers including lack of standardized protocols and provider attitudes. Patients cited trust and potential benefits as facilitators but had concerns about safety and trial participation.", "population_specificity": "Individuals with sickle cell disease (SCD) and clinicians (sickle cell and emergency medicine specialists).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:05.803236+00:00"}
{"study_id": 19365, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antioxidant and antidepressant-like effects of a single subanesthetic dose of ketamine in a rodent model of treatment-resistant depression (TRD) induced by adrenocorticotropic hormone (ACTH).", "results_summary": "Ketamine demonstrated antidepressant effects by reducing oxidative stress markers (O2\u00b7-, AOPP, MDA, TOS) and enhancing antioxidant enzyme activity (SOD, PON1) in ACTH-treated rats, while also mitigating depressive-like behavior and DNA damage in peripheral blood lymphocytes.", "population_specificity": "Male Wistar rats with ACTH-induced TRD.", "effective_dosage": "10 mg/kg, intraperitoneal (single dose).", "study_duration": "Single-dose intervention with behavioral and biochemical assessments post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:06.410643+00:00"}
{"study_id": 19366, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine if adjustable-dose ketamine could reduce opioid use (measured in oral morphine equivalents) and pain scores in severely injured trauma patients.", "results_summary": "The study found no significant difference in opioid use or pain scores between the ketamine and placebo groups at any time point, leading to early termination due to futility. Adjustable-dose ketamine did not demonstrate efficacy in reducing opioid consumption or improving pain management in this population.", "population_specificity": "Severely injured adult trauma patients (ISS \u226515, aged 18-64) admitted to a Level 1 trauma center, excluding those with Glasgow Coma Scale <14, pregnancy, or chronic opioid use.", "effective_dosage": "Adjustable dose starting at 3 \u03bcg/kg/min.", "study_duration": "48-hour study period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:07.582542+00:00"}
{"study_id": 19370, "supplement_id": 1252, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether ketamine impacts cerebral pressure-flow dynamics in patients with moderate/severe traumatic brain injury (TBI), addressing historical concerns about its potential to increase intracranial pressure (ICP).", "results_summary": "The study found higher median ICP in the ketamine group, but this was likely due to differences in patient characteristics rather than ketamine itself. No significant differences were observed in other cerebral pressure-flow dynamics, suggesting ketamine does not adversely affect these metrics.", "population_specificity": "Patients with moderate/severe traumatic brain injury (122 total, 17 received ketamine).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:08.614731+00:00"}
{"study_id": 19371, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the roles of genes encoding monoamine neurotransmitters in the antidepressant effects of low-dose ketamine in patients with treatment-resistant depression.", "results_summary": "The study found that low-dose ketamine's antidepressant effect may involve multiple monoamine neurotransmitter systems and the \u03c31 receptor, with specific genes and SNPs related to cholinergic, dopaminergic, serotonergic, and opioid systems playing pivotal roles.", "population_specificity": "65 patients with treatment-resistant depression", "effective_dosage": "0.5 mg/kg and 0.2 mg/kg ketamine", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:09.897643+00:00"}
{"study_id": 19372, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review and summarize the assessment tools used to measure suicidal behavior in studies investigating ketamine's antisuicidal effects in major depressive disorder patients.", "results_summary": "The study identified 16 assessment tools, with MADRS, HAM-D, and Beck Scales (SSI and BSS) being prominent. Most scales were validated in conventional antidepressant contexts, but MADRS emerged as a recommended choice for rapid-acting antidepressant trials. Heterogeneity in assessment tools may hinder comparisons between ketamine studies.", "population_specificity": "Major depressive disorder patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:11.990540+00:00"}
{"study_id": 19374, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the pharmacokinetic and pharmacodynamic effects of ketamine on PTSD, differentiating between its immediate and sustained molecular effects.", "results_summary": "Ketamine's immediate effects involve changes in GABA, glutamate, and glutamine levels, triggering BDNF re-regulation and synaptic plasticity. Sustained effects include neurotransmitter remodulations, prolonged gene expression changes, and epigenetic modifications, contributing to long-term therapeutic benefits.", "population_specificity": "Preclinical models and clinical trials involving individuals with PTSD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:13.252899+00:00"}
{"study_id": 19375, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ketamine, when added to propofol, had a propofol-sparing effect and how it affected hemodynamic parameters and oxygenation during colonoscopy.", "results_summary": "Ketamine showed no propofol-sparing effect. The study did not report significant adverse effects or benefits related to ketamine use in this context.", "population_specificity": "Patients undergoing colonoscopy under sedation.", "effective_dosage": "Not specified", "study_duration": "Duration of the colonoscopy procedure (exact time not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:13.926804+00:00"}
{"study_id": 19373, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of intravenous Ketamine Adjuvant Treatment (KAT) as an innovative therapy for Anorexia Nervosa (AN) spectrum disorders, focusing on its ability to remodel rigid food-centered thoughts and improve clinical outcomes.", "results_summary": "KAT significantly improved BMI (coefficient 0.71, p=0.002) and showed a tendency to enhance weight regain dynamics after the fourth or fifth infusion. It also reduced AN psychopathology and obsessive-compulsive-like symptoms, such as cognitive rigidity and guilt.", "population_specificity": "Eight female patients aged 16-44 with a diagnosis of AN spectrum disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:14.477897+00:00"}
{"study_id": 19364, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the current knowledge on ketamine's potential as a prophylactic for stress-induced disorders, including its mechanisms, limitations, and risks.", "results_summary": "The study found that ketamine and its metabolites show promise in preventing stress-induced disorders through various neurobiological mechanisms, but highlighted concerns such as age- and sex-specific efficacy, long-term effects, and ethical considerations.", "population_specificity": "Preclinical and clinical studies (general population with stress-induced disorders, including depression, anxiety, PTSD, and postpartum depression).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:15.573501+00:00"}
{"study_id": 19376, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the behavioral effects of R- and S-ketamine in a clinically relevant treatment protocol, focusing on both therapeutic and undesirable psychomotor effects in a depression model and control animals.", "results_summary": "S-ketamine showed stronger acute psychomotor effects than R-ketamine, with Wistar-Kyoto rats (depression model) being more sensitive to these effects. Repeated treatment led to sensitization to locomotor stimulation and tolerance to ataxic effects, but no persistent changes were observed.", "population_specificity": "Wistar-Kyoto rats (depression model) and Wistar rats (control).", "effective_dosage": "10 mg/kg", "study_duration": "Not explicitly stated (repeated treatment protocol).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:15.876499+00:00"}
{"study_id": 19379, "supplement_id": 1252, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether moderate-intensity continuous training (MICT) could reduce the side effects of chronic ketamine abuse, specifically apoptosis and oxidative damage in the cerebral cortex.", "results_summary": "MICT significantly reduced apoptotic cells, decreased Bax and caspase-3 protein expression, increased Bcl-2, lowered oxidative stress markers (OXO), and enhanced antioxidant defenses (GR, GPX, NO) in rats with long-term ketamine abuse.", "population_specificity": "Wistar rats", "effective_dosage": "50 mg/kg/day ketamine for 8 weeks", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:16.759967+00:00"}
{"study_id": 19381, "supplement_id": 1252, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to provide an overview of ketamine's pharmacology and discuss its emerging uses beyond anesthesia, focusing on neuropsychiatric disorders and other conditions.", "results_summary": "The study highlights ketamine's potential in treating substance use disorders, withdrawal syndromes, pain syndromes, and psychomotor agitation, in addition to its established role in depression and suicidality. It emphasizes ketamine's unique pharmacological profile and neuroplastic effects.", "population_specificity": "Patients with neuropsychiatric disorders, substance use disorders, withdrawal syndromes, pain syndromes, and severe psychomotor agitation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:22.014904+00:00"}
{"study_id": 19382, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether D2/D3 receptor modulation (via aripiprazole or raclopride) could suppress ketamine's psychotomimetic side effects while preserving its antidepressant effects.", "results_summary": "Aripiprazole attenuated ketamine's psychotomimetic effects while maintaining or enhancing its antidepressant effects in mice and humans, whereas raclopride suppressed both effects. VTA dopaminergic neuron activation was identified as a key mechanism influencing ketamine's antidepressant efficacy.", "population_specificity": "Mice and depressed human patients (N=9).", "effective_dosage": "12 mg aripiprazole (human study).", "study_duration": "Not specified (abstract only).", "interactions": "Aripiprazole and raclopride (D2/D3 receptor modulators).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:23.455444+00:00"}
{"study_id": 19384, "supplement_id": 1252, "safety_score": "80", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the acute subjective experiences, acceptability, and tolerability of IV ketamine therapy in individuals with alcohol use disorder (AUD).", "results_summary": "IV ketamine therapy was well tolerated and highly acceptable, with participants reporting largely positive, transporting, visual, and meaningful experiences. The most common themes were meaningful/spiritual experiences, positive affect, and inherent contradictions of the acute experience.", "population_specificity": "Inpatient clinical trial participants with alcohol use disorder (AUD) (n=12).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:24.247413+00:00"}
{"study_id": 19386, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to synthesize evidence on non-prescribed ketamine use, focusing on its neurobiological impacts and evaluating psychotherapeutic interventions for addiction.", "results_summary": "The study found that ketamine misuse involves complex neurobiological and socio-psychological factors, with prefrontal-limbic dysconnectivity and HPA axis dysregulation as key mechanisms. It highlighted the potential of biomarkers like BDNF and HRV for personalized interventions but noted gaps in longitudinal data and low-resource settings.", "population_specificity": "Adolescents, women, and polysubstance users (identified as high-risk groups).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:24.324805+00:00"}
{"study_id": 19387, "supplement_id": 1252, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of patient preference and preference-matching on efficacy, adverse events, and adherence to IV ketamine treatment in patients with treatment-resistant depression.", "results_summary": "Ketamine was preferred by more participants than ECT, and preference for ketamine was associated with higher likelihood of treatment response. Preference-matching was linked to greater treatment response for ketamine but not ECT, and reduced adverse events in ECT-treated patients.", "population_specificity": "Patients with treatment-resistant depression across five U.S. sites.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:24.644547+00:00"}
{"study_id": 19385, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to examine the long-term effectiveness of Ketamine-assisted psychotherapy (KAP) on anxiety, depression, and PTSD at 1, 3, and 6 months post-treatment.", "results_summary": "KAP produced large, sustained reductions in anxiety, depression, and PTSD symptoms, with effects lasting up to 6 months post-treatment. However, high attrition rates (82-95%) may limit the validity of these findings.", "population_specificity": "Adults with treatment-resistant major depressive disorder, generalized anxiety disorder, or PTSD.", "effective_dosage": "Mean of 4 ketamine doses (SD=3) via intramuscular injection or sublingual lozenge, with 3 integration sessions (SD=2).", "study_duration": "Follow-up assessments at 1, 3, and 6 months post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:25.219617+00:00"}
{"study_id": 19388, "supplement_id": 1252, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to highlight the underreported side effects of chronic, high-dose ketamine use, specifically K-cramps, and their impact on emergency care.", "results_summary": "The study found that chronic, high-dose ketamine use can lead to severe abdominal pain, nausea, vomiting, and dysuria (K-cramps), which resolved with symptomatic treatment and addiction referral.", "population_specificity": "A 25-year-old woman with a history of anxiety, asthma, obsessive-compulsive disorder, and chronic high-dose ketamine use.", "effective_dosage": "500-1000 milligrams weekly", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:26.234481+00:00"}
{"study_id": 19380, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify biomarkers for ketamine efficacy in treating major depressive disorder (MDD) and explore its mechanisms of action through metabolomics.", "results_summary": "Ketamine modulated energy metabolism pathways, with changes in ADP strongly correlating with symptom improvement. Low baseline FT3 levels predicted better treatment response, suggesting FT3 as a potential biomarker.", "population_specificity": "40 MDD patients in the discovery cohort and 24 in the validation cohort.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:27.608236+00:00"}
{"study_id": 19389, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how nitrous oxide supplemented with ketamine affects subthalamic nucleus electrophysiology compared to awake states and low-dose ketamine sedation during deep brain stimulation procedures.", "results_summary": "Nitrous-ketamine anesthesia allowed subthalamic nucleus identification but reduced beta frequency power compared to ketamine sedation or awake states. Delta frequency oscillations helped delineate subdomains, but motor subregion identification was more difficult under nitrous anesthesia.", "population_specificity": "Parkinson's disease patients undergoing deep brain stimulation targeting the subthalamic nucleus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:29.997673+00:00"}
{"study_id": 19393, "supplement_id": 1252, "safety_score": "80", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of low-dose ketamine and dexmedetomidine on postoperative bowel recovery in patients undergoing gastrointestinal malignancy surgeries.", "results_summary": "Low-dose ketamine did not significantly improve bowel recovery compared to placebo, despite reducing pain scores and opioid consumption. No differences were observed in other secondary outcomes like ICU stay or hospital duration.", "population_specificity": "84 ASA II patients aged 18-70 undergoing elective open GI malignancy surgeries.", "effective_dosage": "Ketamine @ 0.1 mg kg-1 h-1.", "study_duration": "Intraoperative infusion (duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:31.773801+00:00"}
{"study_id": 19391, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of ketamine infusion combined with cervical sympathetic blockade (CSB) in reducing PTSD and blast traumatic brain injury (bTBI) symptoms in Canadian Special Operation Forces Command (CANSOFCOM) members.", "results_summary": "The study found a significant reduction in PTSD symptoms (average reduction of 45.09 on PTSD Checklist-5) and bTBI symptoms (87% reduction in Neurobehavioral Inventory Scale scores) two weeks post-intervention. The results suggest ketamine infusion with CSB provides clinically meaningful symptom relief.", "population_specificity": "Canadian Special Operation Forces Command (CANSOFCOM) members and other patients with PTSD and/or bTBI.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 ketamine infusion and bilateral CSB treatments (duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:32.351352+00:00"}
{"study_id": 19392, "supplement_id": 1252, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the neurobiological mechanisms of ketamine's addictive potential, withdrawal effects, and its impact on brain networks and neurotransmitter systems, as well as its repurposing as a fast-acting antidepressant.", "results_summary": "Ketamine alters brain networks and neurotransmitter systems (glutamate and dopamine), contributing to addiction and withdrawal. Low-dose ketamine affects cortisol secretion and HPA axis dysregulation, potentially explaining its antidepressant effects, but it also carries risks like heart instability, respiratory depression, and liver injury.", "population_specificity": "Global population, with noted prevalence in East and Southeast Asia.", "effective_dosage": "Low-dose mentioned (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:33.398892+00:00"}
{"study_id": 19394, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a predictive model using EHR data to determine whether ECT or ketamine would be the more effective treatment for individual patients with depression.", "results_summary": "The study found that patients who received their predicted optimal treatment (either ECT or ketamine) had significantly lower minimum QIDS scores compared to those who received the non-optimal treatment, suggesting personalized treatment selection improves outcomes. The model identified pretreatment factors to guide antidepressant treatment selection.", "population_specificity": "Patients with depression (2506 ECT and 196 ketamine patients, with propensity score matching yielding 196 per treatment).", "effective_dosage": "Not specified", "study_duration": "Acute treatment period (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:33.728878+00:00"}
{"study_id": 19397, "supplement_id": 1252, "safety_score": "20", "efficacy_score": null, "quality_score": 65, "study_goal": "To review the literature on ketamine-associated upper urinary tract dysfunction, including its pathogenesis and treatment principles.", "results_summary": "Ketamine abuse can lead to upper urinary tract impairment, with symptoms such as bladder dysfunction, inflammation, fibrosis, and papillary necrosis. Oxidative stress, autophagy, and microvascular injury are potential pathogenic mechanisms.", "population_specificity": "Not specified (literature review of existing studies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:34.980198+00:00"}
{"study_id": 19396, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the acute effects of ketamine on mismatch negativity (MMN) and its relationship to early and sustained antidepressant effects in treatment-resistant major depressive disorder (MDD).", "results_summary": "Ketamine reduced frontal MMN amplitudes and theta event-related oscillations, with larger MMN reductions predicting greater symptom improvement, suggesting MMN may serve as a biomarker for antidepressant response.", "population_specificity": "Treatment-resistant MDD patients (N=24).", "effective_dosage": "0.5 mg/kg intravenous ketamine (single infusion).", "study_duration": "Acute effects measured pre-, immediately post-, and 2 hours post-infusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:35.028972+00:00"}
{"study_id": 19399, "supplement_id": 1252, "safety_score": "70", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to compare the safety and efficacy of ketamine versus the B52 combination (diphenhydramine, haloperidol, and lorazepam) for managing agitation in emergency department patients.", "results_summary": "Ketamine was associated with a shorter duration of sedation and a higher need for additional sedatives compared to the B52 combination. Patients receiving ketamine required more frequent and sooner additional sedation (2.1 hours vs. 4 hours for B52).", "population_specificity": "Adult patients with agitation/aggression/combative behavior in the emergency department.", "effective_dosage": "Not specified (study compared ketamine to B52 combination but exact ketamine dosage not mentioned).", "study_duration": "Retrospective study covering January 2018 to December 2023 (intervention duration per patient not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:40.460475+00:00"}
{"study_id": 19400, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate changes in BDNF levels in rodent studies using ketamine-induced schizophrenia models.", "results_summary": "Sub-chronic and chronic ketamine treatment in rats and mice generally decreased BDNF or had no effect, while acute treatment commonly increased BDNF. The effects varied by species, duration of treatment, and sex.", "population_specificity": "Rodents (rats and mice)", "effective_dosage": "Not specified", "study_duration": "Sub-chronic, chronic, and acute treatments (specific durations not provided)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:40.761952+00:00"}
{"study_id": 19401, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of a 12-week ketamine-assisted group therapy program in improving mental health outcomes for firefighters with diagnosed mental health conditions.", "results_summary": "The study found significant reductions in anxiety (GAD-7) and PTSD (PCL-5) scores post-treatment, with large effect sizes, and these improvements persisted six months later. Participants also reported benefits from being in a cohort with fellow firefighters.", "population_specificity": "Firefighters with mental health diagnoses.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:40.909924+00:00"}
{"study_id": 19402, "supplement_id": 1252, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To evaluate the effect of low-dose s-ketamine on cough response during extubation in patients undergoing suspension laryngoscopic surgery.", "results_summary": "Low-dose s-ketamine significantly reduced the incidence of cough response and moderate to severe cough response during extubation compared to the control group, without affecting hemodynamics, recovery, or causing adverse events.", "population_specificity": "66 adult patients (ASA grade I-II) undergoing suspension laryngoscopic surgery.", "effective_dosage": "0.25 mg/kg s-ketamine intravenously after induction.", "study_duration": "Single dose administered during surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:42.567171+00:00"}
{"study_id": 19404, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of ketamine versus electroconvulsive therapy (ECT) in patients with major depressive disorder (MDD).", "results_summary": "Ketamine was found to be non-inferior to ECT in reducing depression symptom severity and response rates, with superior memory function improvement. However, it was associated with higher rates of dissociative symptoms, blurred vision, and dizziness compared to ECT.", "population_specificity": "Patients with major depressive disorder (MDD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:43.166149+00:00"}
{"study_id": 19405, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ketamine could slow or prevent synaptic disruption and behavioral deficits in Alzheimer's disease using a mouse model.", "results_summary": "Ketamine had no effect on amyloid plaque load or auditory gap detection deficits in the 5XFAD Alzheimer's mouse model, regardless of acute or chronic dosing. Chronic ketamine facilitated startle responses in 5XFAD mice, but this was likely due to stress or habituation rather than a therapeutic effect.", "population_specificity": "5XFAD mouse model of Alzheimer's disease", "effective_dosage": "Acute single injection or chronic daily injections", "study_duration": "15 weeks for chronic dosing", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:43.513563+00:00"}
{"study_id": 19403, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize the pharmacokinetics of ketamine in combination with dexmedetomidine and vatinoxan in cats, focusing on how vatinoxan and ketamine dosage affect dexmedetomidine clearance and ketamine bioavailability.", "results_summary": "The study found that vatinoxan increased dexmedetomidine clearance and reduced intramuscular ketamine bioavailability, while higher ketamine doses increased dexmedetomidine's central compartment volume and ketamine bioavailability. Bioavailability for intramuscular ketamine ranged from 60-100%.", "population_specificity": "Six healthy male neutered cats aged 1-2 years, weighing 5.4 \u00b1 0.3 kg.", "effective_dosage": "Ketamine doses of 2.5 mg kg-1, 5 mg kg-1, and 10 mg kg-1, administered intramuscularly, subcutaneously, or intravenously.", "study_duration": "Blood samples were collected up to 6 hours post-administration.", "interactions": "Vatinoxan and dexmedetomidine were noted to interact with ketamine's pharmacokinetics.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:45.423701+00:00"}
{"study_id": 19395, "supplement_id": 1252, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and efficacy of oral racemic ketamine for reducing suicidal ideation and depression in adults with major depressive disorder.", "results_summary": "Oral ketamine significantly reduced suicidal ideation and depression scores compared to midazolam at all assessment points (4h, Day 3, Day 7), with higher response and remission rates. Adverse effects like nausea, emotional disturbance, and depersonalization were more frequent with ketamine but not severe enough to limit treatment.", "population_specificity": "Adults with major depressive disorder and expressed suicidal ideation.", "effective_dosage": "Single session of 3 mg/kg (mean dose: 180 mg).", "study_duration": "Single session, with follow-up assessments at 4h, Day 3, and Day 7.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:45.662461+00:00"}
{"study_id": 19408, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether REM sleep markers, particularly RD1, could predict antidepressant response to ketamine in individuals with treatment-resistant depression (TRD).", "results_summary": "Ketamine decreased RD1 in TRD participants but did not affect Total Night RD or RL. Baseline RD1 levels moderately predicted antidepressant response to ketamine, with higher RD1 associated with better response.", "population_specificity": "63 drug-free individuals with treatment-resistant depression (39 female, 24 male) and 41 healthy volunteers (25 female, 16 male).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:48.250135+00:00"}
{"study_id": 19406, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate ketamine's effects on functional brain connectivity and its antidepressant efficacy in non-resistant major depressive disorder (MDD) patients.", "results_summary": "Ketamine significantly reduced MADRS scores and altered functional connectivity in MDD-related brain circuits at both acute and delayed time points, with no changes observed in non-relevant connections.", "population_specificity": "16 patients with non-resistant major depressive disorder (MDD).", "effective_dosage": "0.5 mg/kg racemic ketamine administered intravenously.", "study_duration": "Acute effects measured at 50, 80, and 165 minutes; delayed effects at 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:48.462512+00:00"}
{"study_id": 19407, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 30, "study_goal": "The researchers aimed to explore whether low-dose sublingual ketamine could improve symptoms of Raynaud's phenomenon in a patient with treatment-resistant depression.", "results_summary": "The study found that low-dose sublingual ketamine significantly improved symptoms of primary Raynaud's phenomenon in the patient. The authors recommend further research into ketamine's potential as a treatment for this condition.", "population_specificity": "A woman with primary Raynaud's phenomenon and treatment-resistant depression.", "effective_dosage": "Low-dose sublingual ketamine (specific dosage not provided).", "study_duration": "Duration of intervention not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:49.509566+00:00"}
{"study_id": 19410, "supplement_id": 1252, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore ketamine's pharmacokinetics, cardiovascular impact, and cellular effects on cardiomyocytes, particularly in insulin-resistant individuals.", "results_summary": "The study found that ketamine has broad therapeutic potential but exacerbates effects on glucose metabolism, mitochondrial function, and oxidative stress in insulin-resistant patients, necessitating careful administration.", "population_specificity": "Insulin-resistant individuals and those with underlying metabolic or cardiovascular conditions.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:49.751690+00:00"}
{"study_id": 19409, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of ketamine in treating refractory focal status epilepticus in a patient with SMART syndrome.", "results_summary": "Ketamine resolved seizures in a patient with SMART syndrome without requiring intubation, suggesting its potential efficacy in this rare condition. The abstract does not report adverse effects or complications from ketamine use.", "population_specificity": "A patient with SMART syndrome experiencing refractory focal status epilepticus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:50.664325+00:00"}
{"study_id": 19414, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of a single infusion of ketamine in inducing rapid remission of severe suicidal ideation compared to Midazolam in patients with acute suicidal thoughts.", "results_summary": "Both ketamine and Midazolam significantly reduced suicidality scores (BSSI and S-VAS) at 12 and 24 hours post-administration, but no statistically significant differences were found between the two treatments.", "population_specificity": "36 inpatients with acute severe suicidal ideation in Tehran, Iran.", "effective_dosage": "0.5 mg/kg (single dose).", "study_duration": "Single administration with follow-up at 12 and 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:51.368087+00:00"}
{"study_id": 19416, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to synthesize current evidence on how ketamine modulates brain systems related to reward processing, interoception, and self-related cognition to understand its antidepressant effects.", "results_summary": "The study suggests ketamine's antidepressant effects are driven by dynamic multi-level influences across key functional domains, including reward processing, interoception, and self-related cognition. However, large-scale neurocognitive mechanisms remain less clearly understood.", "population_specificity": "Not specified (general discussion of ketamine's mechanisms)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:53.352330+00:00"}
{"study_id": 19415, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the safety and feasibility of subanaesthetic ketamine combined with cognitive behavioral therapy for adults with methamphetamine use disorder, while also exploring changes in methamphetamine use, cravings, withdrawal, quality of life, and treatment satisfaction.", "results_summary": "The study assessed safety and feasibility over 8 weeks and secondary outcomes (methamphetamine use, cravings, withdrawal, quality of life, and treatment satisfaction) over 24 weeks, but specific results were not detailed in the abstract.", "population_specificity": "Adults meeting DSM-5-TR criteria for methamphetamine use disorder seeking to reduce or cease methamphetamine use.", "effective_dosage": "Three subcutaneous ketamine doses (0.75 mg/kg to 0.9 mg/kg, titrated according to tolerability) at weekly intervals.", "study_duration": "4-week course with ketamine doses and cognitive behavioral therapy sessions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:55.384898+00:00"}
{"study_id": 19417, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of ketamine and esketamine in preventing postpartum depression (PPD) in women after childbirth.", "results_summary": "Both ketamine and esketamine significantly reduced the incidence of short-term PPD, while only esketamine was effective for long-term PPD. However, higher rates of side effects like dizziness, blurred vision, vomiting, and hallucinations were reported in the ketamine/esketamine groups.", "population_specificity": "Pregnant women after cesarean or vaginal delivery.", "effective_dosage": "Doses less than 0.5 mg were noted as significantly effective.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:56.951553+00:00"}
{"study_id": 19421, "supplement_id": 1252, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the opioid-sparing effect of low-dose ketamine in ICU patients and its association with traumatic memories post-discharge.", "results_summary": "Low-dose ketamine reduced 24-hour fentanyl consumption by 15% but was associated with a higher incidence of frightening and delusional memories after ICU discharge. No acute adverse effects were observed.", "population_specificity": "Adult ICU patients admitted after noncardiac, nonneuro, nontrauma surgery.", "effective_dosage": "1.5 \u00b5g/kg/min", "study_duration": "Not specified (follow-up evaluations occurred 43 \u00b1 8 months post-ICU discharge).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:57.700971+00:00"}
{"study_id": 19419, "supplement_id": 1252, "safety_score": "65", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of ketamine anesthesia combined with electroconvulsive therapy (ECT) versus nonketamine anesthesia with ECT in patients with treatment-resistant depression (TRD).", "results_summary": "Ketamine + ECT showed greater clinical remission and lower HAM-D scores after several ECT sessions compared to nonketamine anesthesia, but it also increased fear with hallucinations. The balance of benefits to harm remains unclear due to potential additional adverse events.", "population_specificity": "Patients with treatment-resistant depression (TRD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:58.400068+00:00"}
{"study_id": 19418, "supplement_id": 1252, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential of racemic ketamine and its enantiomers (R/S) in reducing suicidal ideation or behavior (SIB) through a systematic review of clinical trials.", "results_summary": "Multiple doses of IV ketamine/S-ketamine showed reductions in suicidal ideation for several days to weeks, while single doses had shorter, variable effects. IN and IV ketamine/S-ketamine were well tolerated, and R-ketamine appeared to have fewer side effects, though more research is needed.", "population_specificity": "Individuals with clinically significant suicidal ideation or behavior.", "effective_dosage": "Various routes (IV, IM, IN) and dosing regimens (single vs. multiple doses) were used, but specific amounts and frequencies were not detailed in the abstract.", "study_duration": "Effects were observed from several days to weeks, depending on dosing regimen.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:58.448321+00:00"}
{"study_id": 19422, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore whether the dissociative effects of ketamine and psychedelics are necessary for their antidepressant properties and proposed administering them during sleep to mitigate bias in clinical trials.", "results_summary": "The abstract suggests that dissociative effects might be linked to ketamine's rapid antidepressant action but raises concerns about bias in clinical trials due to patients recognizing active treatment. A novel approach of administering ketamine/psychedelics during sleep is proposed to address these challenges.", "population_specificity": "Not specified (abstract only).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:16:59.164957+00:00"}
{"study_id": 19423, "supplement_id": 1252, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficiency and tolerability of intravenous ketamine in patients with treatment-resistant bipolar depression, focusing on the risk of manic switches, global depressive symptoms, and specific effects on internal tension, sleep disturbance, and suicidal ideation.", "results_summary": "Ketamine significantly reduced MADRS scores without inducing manic switches, with improvements in internal tension, sleep disturbance, and suicidal ideation observed from the second week. Adverse events were generally mild to moderate, and ketamine was well-tolerated despite polypharmacy.", "population_specificity": "Fifty-nine patients with treatment-resistant bipolar I or II disorder (51.4 \u00b1 12.3 years; 30% female).", "effective_dosage": "Mean dose of 0.8 mg/kg intravenously.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:00.748492+00:00"}
{"study_id": 192266, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to examine the pharmacotherapeutic value of inflammatory and neurotrophic biomarkers, including Ketamine, in treating bipolar disorder.", "results_summary": "Ketamine was described to increase both pro-inflammatory (TNF\u03b1, IL-6) and anti-inflammatory (IL-4, IL-8) factors, suggesting a potential role in modulating immune responses in bipolar disorder. However, inconsistencies in the effects of pharmacological treatments on inflammation and symptomatologic improvement were noted.", "population_specificity": "Patients with a diagnosis of bipolar disorder (total of 3371 patients across 40 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:02.785565+00:00"}
{"study_id": 192267, "supplement_id": 1252, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess whether esketamine, as an adjunct to patient-controlled intravenous analgesia (PCIA), could effectively prevent postpartum depression (PPD) in women undergoing cesarean section.", "results_summary": "Esketamine significantly reduced the incidence of PPD (8.2% vs. 17.6% in controls) and lowered sufentanil consumption over 48 hours post-surgery, without increasing adverse effects. Pain scores during movement were also lower in the esketamine group.", "population_specificity": "Postpartum women undergoing cesarean section.", "effective_dosage": "1.5 mg/kg esketamine as a supplement in PCIA.", "study_duration": "48 hours post-surgery (with PPD assessed at 42 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:04.093106+00:00"}
{"study_id": 192268, "supplement_id": 1252, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and safety of esketamine as an adjunct to propofol for sedation during endoscopic procedures in patients.", "results_summary": "Esketamine reduced recovery time and propofol dosage compared to normal saline, with fewer complications than normal saline and opioids, but had a higher risk of visual disturbance. Subgroup analysis suggested 0.2-0.5 mg/kg esketamine was effective and tolerable.", "population_specificity": "Patients undergoing gastrointestinal endoscopy.", "effective_dosage": "0.2-0.5 mg/kg esketamine.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:04.835706+00:00"}
{"study_id": 192269, "supplement_id": 1252, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether a mini-dose combination of esketamine and dexmedetomidine safely improves analgesia and subjective sleep quality after scoliosis correction surgery.", "results_summary": "The study found that the mini-dose esketamine-dexmedetomidine combination significantly improved analgesia and subjective sleep quality compared to patient-controlled sufentanil analgesia alone, with no major safety concerns reported.", "population_specificity": "199 male and female adults undergoing scoliosis correction surgery.", "effective_dosage": "Mean infusion rates were 5.5 \u03bcg kg (specific frequency not detailed in abstract).", "study_duration": "Duration of intervention not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:05.745696+00:00"}
{"study_id": 192271, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers explored the potential of sub-anaesthetic doses of ketamine to normalize dysfunctional neurotransmission in anorexia nervosa and considered its combined use with zinc supplementation.", "results_summary": "The study discussed ketamine's potential role in addressing neurometabolite dysfunction in anorexia nervosa, referencing previous research in neuropsychiatric conditions, but did not present new experimental results. It highlighted promising biological markers for assessing treatment response.", "population_specificity": "Individuals with anorexia nervosa.", "effective_dosage": "Sub-anaesthetic doses (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:06.705885+00:00"}
{"study_id": 192270, "supplement_id": 1252, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ketamine supplementation improves postoperative pain control compared to placebo in patients undergoing septorhinoplasty.", "results_summary": "Ketamine supplementation significantly reduced pain scores at 30 min, 1 h, and 2 h postoperatively and decreased the need for rescue analgesics, but had no significant effect on pain scores at 4 h or the incidence of nausea and vomiting.", "population_specificity": "Patients undergoing septorhinoplasty.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Postoperative period (assessed up to 4 hours).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:08.394918+00:00"}
{"study_id": 192272, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the efficacy and safety of short-term repeated intravenous esketamine infusions in reducing suicidal ideation and depressive symptoms in MDD patients with suicidal ideation.", "results_summary": "The study found that short-term repeated intravenous esketamine infusions showed potential rapid antidepressant effects, but the abstract does not provide specific efficacy results. The trial design supports examining efficacy, safety, and tolerability, but detailed outcomes are not yet reported.", "population_specificity": "MDD patients with suicidal ideation", "effective_dosage": "Not specified in the abstract", "study_duration": "6 days (with infusions every other day) followed by 4 weeks of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:08.458442+00:00"}
{"study_id": 192273, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of ketamine as part of a multimodal nonopioid-based approach for postoperative pain management in ambulatory surgery.", "results_summary": "Ketamine was identified as a potential adjunct for extra analgesia when needed, though its use requires careful consideration of adverse effects like sedation, dizziness, and hypotension in the ambulatory setting. The abstract suggests ketamine may be effective but does not provide specific outcome data.", "population_specificity": "Ambulatory surgery patients requiring postoperative pain management.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:08.586489+00:00"}
{"study_id": 192275, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical efficacy of ketamine versus control in reducing postoperative pain and analgesia consumption during cesarean section anesthesia.", "results_summary": "The meta-analysis found that ketamine reduced pain scores, decreased morphine consumption, and prolonged the time to first analgesia request compared to the control group. The results were statistically significant and clinically meaningful.", "population_specificity": "Women undergoing cesarean section (1,737 patients across 20 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:11.891754+00:00"}
{"study_id": 192274, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the potential of the mismatch negativity (MMN) as a biomarker for monitoring the effects of NMDAR antagonists like ketamine in treating major depressive disorder (MDD).", "results_summary": "The study found that ketamine and other NMDAR antagonists show promise for rapid antidepressant effects, but the lack of standardized methodology for MMN limits its current utility in drug development. The research highlights distinctions in mechanisms of NMDAR antagonism when studied under different paradigms.", "population_specificity": "Patients with major depressive disorder (MDD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:12.816220+00:00"}
{"study_id": 192276, "supplement_id": 1252, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ketamine supplementation improves pain management and reduces ischemia reperfusion injury in patients undergoing knee arthroscopy.", "results_summary": "Ketamine supplementation significantly improved pain scores, reduced analgesic consumption, delayed the time to first analgesic requirement, and showed no increase in nausea and vomiting. It also suggested a potential reduction in ischemia reperfusion injury.", "population_specificity": "Patients undergoing knee arthroscopy (300 participants across 7 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:13.399298+00:00"}
{"study_id": 192277, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore whether creatine exhibits rapid antidepressant effects similar to ketamine, based on preclinical and clinical evidence.", "results_summary": "The study suggests that creatine may have antidepressant properties, with potential mechanisms similar to ketamine, based on animal models of depression. Evidence indicates a possible rapid antidepressant effect, though clinical relevance requires further investigation.", "population_specificity": "Animal models of depression (preclinical) and general clinical evidence (not population-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:13.602975+00:00"}
{"study_id": 192278, "supplement_id": 1252, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ketamine administered via PCA provides adequate analgesia while reducing opioid consumption in traumatically injured patients, compared to hydromorphone PCA.", "results_summary": "Ketamine PCA led to significantly lower cumulative opioid consumption and reduced oxygen supplementation requirements compared to hydromorphone PCA, though hallucinations occurred more frequently with ketamine. No difference was found in median daily breakthrough opioid use between the two groups.", "population_specificity": "Nonintubated trauma patients in intensive care receiving PCA.", "effective_dosage": "Not specified in the abstract.", "study_duration": "First 72 hours of therapy.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:15.361494+00:00"}
{"study_id": 192281, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review literature and highlight current practices for managing chronic pain patients undergoing surgery, including the use of ketamine as part of multimodal analgesia.", "results_summary": "The study suggests that ketamine, among other pharmaceutical agents, can be effective as part of intraoperative multimodal analgesia for chronic pain patients. It emphasizes the importance of perioperative considerations but does not provide specific data on ketamine's efficacy.", "population_specificity": "Chronic pain patients presenting for surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:16.350338+00:00"}
{"study_id": 192280, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether a combination of ketamine and remifentanil improves postoperative analgesia compared to remifentanil alone in patients undergoing laparoscopic cholecystectomy.", "results_summary": "The study found no significant difference in postoperative pain severity, time to first analgesic supplementation, or morphine consumption between the ketamine-remifentanil group and the remifentanil-only group. Adverse effects were not significantly different between the groups.", "population_specificity": "40 patients undergoing video laparoscopic cholecystectomy.", "effective_dosage": "Ketamine (5 mcg.kg(-1).min(-1)) and remifentanil (0.4 mcg.kg(-1).min(-1)).", "study_duration": "24 hours postoperatively.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:17.449602+00:00"}
{"study_id": 192279, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if adding ketamine reduces remifentanil-induced hyperalgesia, improves analgesia, and alters IL-6, IL-8, and IL-10 levels in patients undergoing laparoscopic cholecystectomy.", "results_summary": "The study found no significant differences in pain intensity, morphine consumption, or cytokine levels between groups. Ketamine showed a minor reduction in hyperalgesia in one test (monofilaments) but no other measurable benefits.", "population_specificity": "56 patients aged \u226518, ASA I or II, undergoing laparoscopic cholecystectomy.", "effective_dosage": "5 \u03bcg/kg per minute of ketamine.", "study_duration": "Administered during surgery (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:17.478267+00:00"}
{"study_id": 192283, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers examined whether adding dexmedetomidine to caudal bupivacaine could improve pain control during inguinal hernia repair in children, reducing the need for ketamine rescue.", "results_summary": "The study found that adding dexmedetomidine significantly reduced the need for ketamine rescue (3.33% vs. 43.33%) and prolonged postoperative analgesia, with lower fentanyl consumption in the dexmedetomidine group.", "population_specificity": "Children aged 12-72 months undergoing unilateral inguinal hernia repair.", "effective_dosage": "Ketamine rescue dose: 2 mg/kg (administered as needed).", "study_duration": "Not specified (single surgical procedure).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:21.397664+00:00"}
{"study_id": 192282, "supplement_id": 1252, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether a ketamine-remifentanil combination improves postoperative analgesia compared to remifentanil alone in patients undergoing laparoscopic cholecystectomy.", "results_summary": "The study found no significant difference in postoperative pain severity, time to first analgesic supplementation, or morphine consumption between the ketamine-remifentanil group and the remifentanil-only group.", "population_specificity": "40 patients undergoing video laparoscopic cholecystectomy.", "effective_dosage": "Ketamine (5 mcg.kg(-1).min(-1)) and remifentanil (0.4 mcg.kg(-1).min(-1)).", "study_duration": "24 hours postoperatively.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:21.592590+00:00"}
{"study_id": 19624, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to determine whether a ketogenic diet could effectively reduce symptoms of obsessive-compulsive disorder (OCD) in individuals.", "results_summary": "The study found that three participants achieved remission of OCD symptoms and became medication-free after adopting a ketogenic diet, with an average 90.5% reduction in Y-BOCS scores. Symptoms returned when participants deviated from the diet.", "population_specificity": "Individuals with obsessive-compulsive disorder (OCD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:21.795540+00:00"}
{"study_id": 19625, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a ketogenic diet (KD) reverses age-related cognitive decline by examining synaptic protein changes in the hippocampus and prefrontal cortex of aging rats.", "results_summary": "The study found that KD did not significantly alter synaptic protein levels in isolated synaptosomes but disrupted natural protein correlations seen in control-fed rats. KD also altered the excitatory/inhibitory synaptic vesicle ratio in the prefrontal cortex but not the hippocampus.", "population_specificity": "Aging rats", "effective_dosage": "Not specified", "study_duration": "Minimum of 4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:22.545994+00:00"}
{"study_id": 19626, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and validate a questionnaire to assess parental perceptions of the ketogenic diet (KD) and evaluate changes in these perceptions after a structured educational intervention.", "results_summary": "Post-intervention, parental understanding, perceived effectiveness, and motivation significantly improved, while concerns about side effects, financial burden, and long-term adherence decreased. The questionnaire demonstrated high internal consistency, and positive impacts on child quality of life were noted.", "population_specificity": "Parents of children (aged one month to five years) with drug-resistant epilepsy.", "effective_dosage": "Not specified", "study_duration": "Three months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:23.613616+00:00"}
{"study_id": 19627, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a very low-calorie ketogenic diet (VLCKD) could slow obesity-related epigenetic aging by analyzing changes in biological age estimates.", "results_summary": "The study found that individuals with obesity showed accelerated biological age compared to normal-weight individuals, but those following a VLCKD experienced a deceleration in biological age, correlated with BMI, ketonemia, and metabolic improvements.", "population_specificity": "Individuals with normal weight (n = 20), obesity (n = 24), and patients with obesity following a VLCKD (n = 10).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:24.931720+00:00"}
{"study_id": 19629, "supplement_id": 1253, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical efficacy and safety of the classic ketogenic diet (cKD) and its variants in patients with genetically confirmed drug-resistant epilepsy.", "results_summary": "The study found that ketogenic diets induce metabolic shifts, enhance mitochondrial function, and modulate neurotransmitter balance, showing efficacy in genetic epilepsies like Dravet syndrome and Angelman syndrome. However, genetic factors influence safety, with contraindications for certain metabolic disorders.", "population_specificity": "Patients with genetically confirmed drug-resistant epilepsy, including conditions like GLUT1DS, PDCD, Dravet syndrome, tuberous sclerosis complex, and Angelman syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:26.183214+00:00"}
{"study_id": 19628, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate whether causative genetic variants could predict seizure response to the ketogenic diet in children with drug-resistant epilepsy.", "results_summary": "The study found that 61.1% of children achieved \u226550% seizure reduction at 3 months, with sustained efficacy in some cases up to 2 years. Genetic variants in specific genes (e.g., SLC2A1, SCN1A) were associated with better response, while others (e.g., COL4A1, DYNC1H1) showed lack of response.", "population_specificity": "226 children (118 girls, 108 boys) with refractory epilepsy, median age 5.1 years, 87% with intellectual disability.", "effective_dosage": "Classic ketogenic diet (specific ratio not detailed).", "study_duration": "At least 3 months, with follow-up up to 2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:27.956849+00:00"}
{"study_id": 19632, "supplement_id": 1253, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "To determine the clinical and metabolic effects of a well-formulated ketogenic diet in children with obesity and associated metabolic disorders.", "results_summary": "The study found significant weight loss (average 6.45 kg), reduced BMI (3.12 kg/m\u00b2), improved insulin resistance markers, decreased hepatosteatosis, and fewer cases of metabolic syndrome and hypertension. Positive health changes were noted, though some difficulties in diet adherence were reported.", "population_specificity": "100 children with obesity and metabolic disorders (58 completed the study).", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:28.728483+00:00"}
{"study_id": 19634, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess the impact of a very low-calorie ketogenic diet (VLCKD) on anthropometric measurements, inflammatory biomarkers, metabolic health, and cardiovascular risk in psoriatic arthritis (PsA) patients with moderate overweight or class I obesity.", "results_summary": "The study found that VLCKD significantly improved PsA activity, metabolic health, and cardiovascular parameters, with greater benefits observed in patients with higher baseline BMI or less controlled disease. Most inflammatory biomarkers remained within normal limits, and BMI reduction correlated with improvements in disease activity.", "population_specificity": "Psoriatic arthritis (PsA) patients with BMI \u226527 and <35, in stable remission or low disease activity.", "effective_dosage": "Not specified (very low-calorie ketogenic diet regimen).", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:31.090112+00:00"}
{"study_id": 19633, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of a ketogenic diet on KCC2 expression in specific brain regions of rats with seizures induced by amygdaloid kindling, and its potential neuroprotective effects.", "results_summary": "The ketogenic diet reduced after-discharge duration, increased latency and duration of generalized seizures, and prevented kindling-induced reduction of KCC2 expression in dentate gyrus and CA3 regions, suggesting a neuroprotective effect. Higher KCC2 expression correlated with shorter seizure duration.", "population_specificity": "Male Sprague Dawley rats with induced seizures via amygdaloid kindling.", "effective_dosage": "Not specified (high-fat, low-carbohydrate, adequate protein diet).", "study_duration": "From postnatal day 24 until the end of the experiment (6 weeks post-diet initiation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:31.309682+00:00"}
{"study_id": 19637, "supplement_id": 1253, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical evidence regarding the impact of ketogenic diets on hepatic steatosis in Metabolic dysfunction-associated steatotic liver disease (MASLD).", "results_summary": "Ketogenic diets significantly reduce hepatic fat content and improve metabolic parameters, including insulin sensitivity and liver enzyme levels, but potential adverse effects like dyslipidaemia and gastrointestinal disturbances require monitoring.", "population_specificity": "Individuals with Metabolic dysfunction-associated steatotic liver disease (MASLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:31.734149+00:00"}
{"study_id": 19635, "supplement_id": 1253, "safety_score": "85", "efficacy_score": 95, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical effects of a personalized ketogenic diet (KMT 1:5:1 ratio) on obsessive-compulsive disorder (OCD), ulcerative colitis (UC), and metabolic health in an adult patient.", "results_summary": "The study found complete remission of OCD, clinical remission of UC, and significant improvements in metabolic health, body composition, and quality of life (flourishing, resilience, self-compassion) within 12 weeks of the ketogenic diet intervention.", "population_specificity": "A 37-year-old obese woman with longstanding OCD and ulcerative colitis.", "effective_dosage": "Personalized whole-food ketogenic diet (KMT 1:5:1 ratio).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:32.068628+00:00"}
{"study_id": 19636, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether a new-formulated ketogenic diet (KD) based on vegetal fat could improve liver alterations associated with metabolic dysfunction-associated steatohepatitis (MASH) in mice.", "results_summary": "The study found that the KD significantly increased ketone body production, reduced liver and body weights, improved glucose and lipid metabolism, and ameliorated MASH-associated gut dysbiosis, hepatic steatosis, parenchymal injury, and liver fibrosis. Mechanistically, the KD reduced pro-inflammatory and pro-fibrogenic markers in the liver.", "population_specificity": "C57BL/6 mice with induced MASH.", "effective_dosage": "Not specified.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:32.436241+00:00"}
{"study_id": 19638, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the ketogenic diet in managing neurodegenerative diseases by examining its mechanisms of action, historical context, and therapeutic efficacy.", "results_summary": "The study found that the ketogenic diet shows promise in mitigating neurodegenerative disease progression by enhancing mitochondrial efficiency, reducing oxidative stress, and modulating inflammatory pathways. It also linked the diet to improved cognitive function, reduced motor symptoms, and enhanced mitochondrial activity in patients with neurodegenerative disorders.", "population_specificity": "Patients with neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:34.554740+00:00"}
{"study_id": 19640, "supplement_id": 1253, "safety_score": "80", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of the ketogenic diet in reducing seizure frequency and improving cognition in children with Rett syndrome.", "results_summary": "The study found that 67% of children had \u226550% improvement in seizure frequency at 6 months, and 44% maintained this improvement at 12 months. Patients with significant seizure reduction also showed improved cognition and alertness, and the diet was well tolerated.", "population_specificity": "9 children with Rett syndrome and refractory epilepsy, all with gastrostomy tubes.", "effective_dosage": "8 started with a ketogenic formula, 1 with a food-based diet (specific amounts not detailed).", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:38.072977+00:00"}
{"study_id": 19642, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of a ketogenic diet on depression-like behaviors in mice and investigate its underlying mechanisms, focusing on neuroinflammation and hippocampal neurogenesis.", "results_summary": "The ketogenic diet significantly alleviated depression-like behaviors in mice, reduced neuroinflammation markers, and promoted hippocampal neurogenesis by enhancing BDNF/TrkB/CREB and Wnt/\u03b2-catenin signaling pathways.", "population_specificity": "Mice subjected to chronic unpredictable mild stress (CUMS)-induced depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:38.455746+00:00"}
{"study_id": 19639, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the pattern of beta-hydroxybutyrate (BHB) levels in the first three months of ketogenic diet (KD) therapy and establish a physiological reference range for BHB to ensure efficacy in treating drug-resistant epilepsy.", "results_summary": "BHB levels rose rapidly to 2.0 mmol/L at 19 hours, peaked at 4.2 mmol/L at 43 hours, and stabilized by three months. The reference range for effective KD therapy was determined to be 1.1 to 4.9 mmol/L, with responders (\u226550% seizure reduction) showing efficacy at BHB levels \u22651.1 mmol/L.", "population_specificity": "300 patients with drug-resistant epilepsy, predominantly undergoing a fasting initiation strategy (84% fasted 24-48 hours).", "effective_dosage": "Not specified (dietary intervention, not a supplement dosage).", "study_duration": "Three months (with intensive monitoring in the first week).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:38.534006+00:00"}
{"study_id": 19641, "supplement_id": 1253, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of intermittent fasting combined with a ketogenic diet versus a routine diet on AMPK levels and tumor markers in breast cancer patients undergoing chemotherapy.", "results_summary": "The ketogenic diet group showed the most significant increase in AMPK levels and a greater reduction in CA 15-3 levels compared to the routine diet group, suggesting potential benefits for cancer patients.", "population_specificity": "45 breast cancer patients receiving chemotherapy.", "effective_dosage": "Not specified (only mentions 23:1-h intermittent fasting combined with a ketogenic diet).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:39.336560+00:00"}
